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1 Introduction 
1.1 Biological membranes 
Biological membranes consist of a continuous double layer of lipid molecules 
in which membrane proteins are embedded. The lipid compositions of the 
inner and outer monolayers also differ, reflecting the distinct functions of the 
two faces of a cell membrane. This lipid bilayer is fluid and amphipathic, with 
individual lipid molecules able to diffuse rapidly within their own monolayer. 
The lipid molecules with the most extreme asymmetry in their membrane 
distribution are the sugar-containing lipid molecules. With exception of 
glucosylceramide these molecules are found exclusively in the noncytosolic 
monolayer of the lipid bilayer, where they are thought to partition preferentially 
into lipid rafts. (Small region of the plasma membrane enriched in sphingolipids 
and cholesterol) (Ko et al. 1998). 
There are three major classes of membrane lipid molecules—phospholipids, 
cholesterol, and glycolipids. In the plasma membrane, the oligosaccharide 
headgroups are exposed towards the extracellular surrounding, where they 
have important roles in interactions of the cell with its surroundings such as in 
microbial pathogenesis or signal transduction. 
 
1.2 Glycosphingolipids 
Glycosphingolipides (GSLs) which are anchored on the extracytosolic leaflet of 
the plasma membrane of eukaryotic cells. GSLs are composed of a ceramide 
moiety and a hydrophilic, extracellularly oriented oligosaccharide headgroup at 
the 1-hydroxyl moiety. On the cell surface GSLs serve not only for the cell-cell 
recognition but also as binding sites for toxin, virus and bacteria, which bind to 
the oligosaccharide headgroup of GSLs (Karlsson 1989). A subfamiliy of the 
GSLs are the gangliosides, which are composed of a glycosphingolipide with 
one or more sialic acids linked to the sugar chain. They have been found to be 
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highly important in immunology. Natural and semisynthetic gangliosides are 
considered potential therapeutics for neurodegenerative disorders (Mocchetti 
2005).
De novo biosynthesis requires the coordinate action of several enzymes 
(Stoffel 1973; Stoffel and Bister 1974; Stoffel and Melzner 1980; Stoffel and 
Sticht 1967) including serin palmitoyl transferase and ceramide synthase to 
generate ceramide. This process begins with the condensation of serine and 
palmitoyl-CoA to form 3-ketosphinganine and is localized on the cytosolic face 
of the endoplasmic reticulum. 2-Ketosphinganine is reduced to the sphingoid 
base to D-erythro-sphinganine (Mandon et al. 1992) and acylated to 
dihydroceramide by ceramide synthase. Dihydroceramide is oxidized then by 
the dihydroceramide-desaturase to ceramide (Michel et al. 1997; Rother et al. 
1992).  
To date, six ceramide synthase isoenzymes have been described in 
vertebrates and many other homologues in other organisms such as yeast, 
drosophila. The vertebrate ceramide synthases are encoded by the longevity 
assurance (lass) genes 1–6 (Lahiri and Futerman 2005; Mizutani et al. 2005; 
Pewzner-Jung et al. 2006; Riebeling et al. 2003). Each isoenzyme shows 
group specificity for particular fatty acids, leading to the lass gene-controlled 
biosynthesis of ceramide and ceramide derivatives with a specific fatty acid 
composition. C16 ceramide is one of the main ceramide species which 
synthesis is catalyzed by the gene products of lass 5 and 6, while ceramides 
with longer chains such as C20 and C24 ceramides are mainly synthesized by 
lass 2 and 4, which are found in the hippocampus (Wang et al. 2008).  
Ceramide synthesis occurs in the endoplasmic reticulum (ER) and that of 
sphingomyelin and complex GSLs in the Golgi apparatus. As the hydrophobic 
nature of ceramide prevents its spontaneous transfer through the cytosol 
(Venkataraman and Futerman 2001), it must travel from the ER to the Golgi 
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apparatus by facilitated mechanisms. This was demonstrated to occur by both 
vesicular and non-vesicular transport (Fukasawa et al. 1999).  
Of great importance is the isolation and characterization of a protein, CERT, 
previously called the Goodpasture antigen-binding protein that transports 
ceramide between the ER and the Golgi apparatus (Hanada et al. 2003). The 
two important binding domains of CERT are the pleckstrin homology (PH) 
domain, which targets the proteine to the Golgi, and the steroidogenic acute 
regulatory protein (STAR)-related lipid transfer (START) domain, a conserved 
lipid-binding domain that associates with sterols and ceramide (Bieberich 2008; 
Kudo et al. 2008). It is assumed that ceramide transported by CERT is used for 
sphingomyelin biosynthesis while that converted to glycosphingolipids follows 
the classical vesicular route (Hanada et al. 2003; Kumagai et al. 2005).  
At this point, it should be noted that ceramide may also distribute throughout 
specialized ER compartments, such as the perinuclear membrane and the 
mitochondrial-associated ER membrane (MAM).(Bieberich 2008) This latter 
point is particularly important as evidence is now emerging that sphingolipid 
metabolism can occur in unexpected subcellular locations such as in the 
nucleus and in mitochondria (Bionda et al. 2004), and not just in the 
sub-fractions of the ER membrane that are tightly associated with these 
organelles, although it is not entirely clear whether ceramide is synthesized in 
these organelles or transported from the ER (Albi et al. 2006; Albi et al. 2008; 
Bionda et al. 2004; Ledeen and Wu 2006, 2008). A neutral ceramidase has 
also been found in mitochondria (El Bawab et al. 2000), and there is evidence 
for a sphingomyelin cycle in the nucleus (Watanabe et al. 2004). Recent 
studies suggest that ceramide is involved in the initiation of apoptosis by 
forming pores in the outer mitochondrial membrane (Siskind et al. 2006). 
At present, nothing is known about whether CERT, or perhaps other putative 
ceramide-binding proteins, is involved in regulating ceramide levels in any of 
the intracellular signalling pathways in which it is involved. 
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After transport to the Golgi apparatus, ceramide is glycosylated on the 
cytosolic side of the Golgi apparatus to glucosylceramide. Although it may be 
regulated this transbilayer movement becomes a rate-limiting step (Hannun 
and Obeid 2008). In the Golgi lumen, sphingomyelin is synthesized by 
sphingomyelin synthase (SMS)1 and then transported to the cell membrane) 
(Ding et al. 2008; Guillen et al. 2007; Tafesse et al. 2006). SMS1 is distinct 
from SMS2, which regenerates sphingomyelin from ceramide in the cell 
membrane (Bieberich 2008; Huitema et al. 2004; Vos et al. 1995). 
The biosynthesis of higher GSLs takes place in the lumen of the Golgi 
apparatus. They are synthesized by sequentially acting, membrane-bound 
glycosyltransferases and transported to the cell surface by a vesicular 
membrane flow (Schwarzmann and Sandhoff 1990).(Fig. 1-1) 
 
 
Fig. 1-1 In the Golgi, ceramide is used as precursor substrate for glycosphingolipid 
and sphingomyelin biosynthesis. Sphingomyelin is then transported to the cell 
membrane. Ceramide generated by the degradation of sphingomyelin in the 
endosomal/ lysosomal pathway can be hydrolyzed to sphingosine and recycled back 
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to the ER mediated by the ‘salvage pathway’ (dashed arrows). Ceramide generated in 
the ER can be transported to the nucleus (via perinuclear ER cisternae) and the 
mitochondria (via mitochondrial-associated ER membrane). Ceramide can also be 
converted to ceramide 1-phosphate (C1P) or to sphingosine and subsequently to 
sphingosine 1-phosphate (S1P) CERT: Ceramide transport protein; CK: Ceramide 
kinase; SK: Sphingosine kinase; SMase: Sphingomyelinase; SMS: Sphingomyelin 
synthase; SPT: Serine palmitoyltransferase. From (Bieberich 2008)) 
 
In terms of complexity, at least five different sphingoid bases are known in 
mammalian cells, more than 20 species of fatty acids, which are varying in 
chain length, degree of saturation, and degree of hydroxylation, can be 
attached to the sphingoid base, and around 500 different carbohydrate 
structures have been described in GSLs, although there is often some 
preference for association of specific components in specific sphingolipids. 
The degradation of plasma membrane-derived GSLs takes place in the acidic 
compartments (late endosome and lysosome) of the cell (Zeller and Marchase 
1992); (Sandhoff and Kolter 2003). According to a hypothesis for the topology 
of lysosomal digestion, GSLs are internalized from the plasma membrane and 
transported to lysosomes through the endocytotic pathway as 
membrane-bound components of intraendosomal and intralysosomal vesicles 
(Furst and Sandhoff 1992), which bud from the endosomal membrane into the 
endosomal lumen and are presumably engulfed in budding vesicles to be 
transported to the lysosomes. These vesicles might fuse with the lysosoms 
releasing the intralysosomal vesicles into the lysosol where the lipids are in the 
correct orientation to be degraded (Fig. 1-2). The lysosomal perimeter 
membrane, however, is protected from degradation by a glycocalix composed 
of the oligosaccharide headgroups of LIMPs (lysosomal integral membrane 
proteins) and LAMPs (lysosomal associated membrane proteins; (Carlsson 
and Fukuda 1990; Linke 2000) 
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Fig. 1-2: Model for the topology of lysosomal GSL digestion. Parts of the plasma 
membrane, including GSLs, are incorporated into the membranes of intra-endosomal 
vesicles and membrane structures during endocytosis. The vesicles reach the 
lysosomal compartment when late endosomes are transiently fused with primary 
lysosomes and are degraded there, adapted from (Kolter and Sandhoff 2005). GSL: 
Glykosphingolipide, EGFR: epidermal growth factor receptor (Möbius et al. 2003; 
Schulze et al. 2008) 
 
The lysosomal degradation of GSLs with oligosaccharide headgroups and of 
the sphingolipid ceramide is a sequential pathway. For the degradation of the 
GSL with short oligosaccharide headgroups several of these enzymes requires 
the coordinate action of acidic hydrolases and sphingolipid activator proteins 
(SAPs), (Linke et al. 2001). The SAPs are small glycoproteins, the saposins 
Sap-A, -B, -C,-D and the GM2-activator protein (Sandhoff et al. 2001). 
 
1.3 Sphingolipid activator proteins (SAPs) 
Sphingolipid activator proteins (Saposin) are highly homologous, small, 
nonenzymatic proteins. They belong to the large and divergent family of 
saposin-like proteins (SAPLIPs) and domains containing the ‘‘saposin fold’’ 
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characterized by four or five adjacent amphipathic α helices forming bundles 
stabilized by conserved disulfide bridges or by cyclization (Gonzalez et al. 
2000). The all-helical core structure of SAPLIPs is adapted to carry out a 
number of different functions at biological membranes. 
Despite their similar structures, each saposin promotes the degradation of 
particular sphingolipids by a specific enzyme or partially overlapping sets of 
enzymes (Kolter et al. 2005). Current models for enzyme activation address 
the location of saposin-mediated lipid–hydrolase interactions and define the 
‘‘solubilizer’’ and ‘‘liftase’’ modes of action (Wendeler et al. 2004; Wendeler et 
al. 2006). In the former model, target lipid molecules are extracted from 
bilayers by saposins and presented to cognate enzymes as soluble 
protein–lipid complexes. In contrast, the ‘‘liftase’’ model involves the binding of 
enzyme to the bilayer surface where saposin molecules facilitate the access to 
the glycosphingolipid substrates. For example, Sap-B is thought to be a 
detergent-like lipid solubilizer (Remmel et al. 2007; Yuan et al. 2007), whereas 
Sap C may act as a liftase at the bilayer surface (Wilkening et al. 1998). 
Sap-D is involved in vivo in ceramide hydrolysis by acid ceramidase, it 
enhances the degradation of ceramide both in cell culture and in vitro (Klein et 
al. 1994; Linke et al. 2001). However, the exact mode of ceramidase activation 
by Sap-D has not yet been investigated in detail and will be subject of the 
following thesis. 
 
1.4 The salvage pathway 
In addition to sphinganine, ceramide synthase accepts sphingosine as a 
substrate for the acylation reaction, which is an essential step in so called 
salvage pathway of ceramide biosynthesis (Fig. 1-3). Sphingosine serves as 
the product of sphingolipid catabolism, and it is mostly salvaged through 
reacylation, resulting in the generation of ceramide or its derivatives (Gillard et 
al. 1998a; Gillard et al. 1998b; Gillard et al. 1996; Kitatani et al. 2008). This 
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recycling of sphingosine is termed the "salvage pathway", and recent evidence 
points to important roles for this pathway in ceramide metabolism and function 
since many processes involving ceramide as an apoptosis inducer appear to 
be related to ceramide in a perinuclear, possibly endosomal, compartment 
(Kitatani et al. 2008).The salvage pathway is also interesting with respect to 
the fatty acid specificity of ceramide synthase. 
A number of enzymes are involved in the salvage pathway, and these include 
sphingomyelinases, cerebrosidases, ceramidases, and ceramide synthases. 
Recent studies suggest that the salvage pathway is not only subject to 
regulation, but it also modulates the formation of ceramide and subsequent 
ceramide- derivatives to proapoptotic ceramide and ceramide dependent 
cellular signals. 
Before the salvage pathway can utilize ceramide, it has to be converted into its 
derivatives. To achieve this, ceramide is transported from the ER to the Golgi 
apparatus following two distinct transport routes. 
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Fig. 1-3: The salvage pathway. Depicted are the metabolic pathways for ceramide 
synthesis as well as the de novo pathway and the exogenous ceramide-recycling 
pathway, and the salvage pathway. Dotted lines indicate the recycling/salvaging 
pathway of ceramide synthesis. From (Kitatani et al. 2008) 
 
 
1.5 Ceramides and ceramidases 
Ceramides are important building blocks of eukaryotic membranes. It is 
assumed that they are segregated in microdomains in the lateral plane of the 
lipid bilayer that are enriched in other sphingolipids and cholesterol (Munro 
2003). Some of the microdomains were believed to be tightly packed, ordered 
membrane domains that are generally enriched in both lipids with saturated 
acyl chains (e.g., sphingolipids) and sterol (London 2002; Schroeder et al. 
1994). They are believed to segregate from disordered membrane domains 
that are rich in lipids with unsaturated acyl chains (London 2002; Megha et al. 
2007). Their formation might be driven, at least in part, by the affinity of 
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cholesterol for specific sphingolipids, although the precise biophysical rules 
that determine how cholesterol interacts with different sphingolipids have not 
yet been fully elucidated and may yield surprises. During the last few years it 
became clear, that lipid microdomains are complex dynamic structures in 
membranes, in which lipids and proteins are interacting in order to express their 
function. So far it is known that there are different forms of such microdomains. 
Lipid-lipid interactions play a major role in lipid phase separation. Among others 
liquid ordered and liquid disordered phases depend on the physical conditions 
such as temperature and lateral pressure, and the types of lipids. Other 
membrane domains are due to protein-protein interactions. A third type of 
microdomains results form lipid-protein interactions, which tend to form so 
called lipid shells to improve the protein activity 
(AFM) and Fluorescence-Correlation Spectroscopy (FCS) as well as emission 
depletion (STED) far-field fluorescence nanoscopy studies showed that unlike 
phosphoglycerolipids, sphingolipids are transiently (10–20 ms) trapped in 
cholesterol-mediated molecular complexes within 20-nm diameter areas. Only 
long chain ceramides, with a backbone of 16 to 18 carbon atoms, can 
segregate from the other lipids of a membrane bilayer composed of SM, DOPC 
and cholesterol and form ceramide-enriched domains (Chiantia et al. 2007; 
Chiantia et al. 2008; Eggeling et al. 2008). However, it is also now becoming 
evident that the detergent resistant membranes (DRMs) often called as “Lipid 
rafts” and lipid microdomains are two different concepts, albeit possibly having 
certain properties or components in common. Up to now, there is no proof that 
lipid rafts exist in the plasma membrane of living cells (for review see (Gallala 
and Sandhoff 2008)) 
Under some conditions it has been reported that activation of SMase leads to 
the generation of ceramide-rich membrane domains on the plasma membrane, 
which can exist in the form of large ceramide-rich platforms (Grassme et al. 
2001; Grassme et al. 2003). The formation and functional role of ceramide-rich 
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domains have been reviewed recently (Bollinger et al. 2005; Gallala and 
Sandhoff 2008). 
Natural ceramide has a long saturated N-acyl chain and small polar headgroup, 
making it a lipid with very tight packing properties. Model membranes 
composed of ceramide have a high order-to-disorder transition temperature 
(Megha et al. 2007; Shah et al. 1995). Surprisingly, long chain ceramide has 
the ability to stabilize and promote microdomain formation in model 
membranes (Megha and London 2004; Xu et al. 2001) and have the ability to 
displace sterols from lipid microdomains, a fact that seems to be relevant for 
the degradation of intralysosomal membranes (Alanko et al. 2005; Megha and 
London 2004; Yu et al. 2005). Some years ago, a gradual displacement of 
sterol has also been observed in endocytic membranes on their way to the 
lysosomes by Möbius et al. in electron microscopy studies (Möbius et al. 2003). 
While early endosomes still contain sterols in high amounts, they will be 
displaced by ceramide, when the intralysosomal membranes are formed. The 
sterols must be recycled from the endosomal compartment. (Megha et al. 
2007) 
Ceramides are not only components of the membrane structure, they also are 
involved in several signaling pathways and microbial pathology (Heung et al. 
2005) The levels of ceramide in vivo are carefully regulated. Hannun and 
coworkers provided evidence that ceramide is a second messenger (Okazaki 
et al. 1990). So far, not only ceramide but also its metabolites such as 
ceramide 1-phosphate, sphingosine, and sphingosine 1-phosphate (S1P) are 
now recognized as messengers playing essential roles in events as diverse as 
differentiation, senescence, proliferation, and cell cycle arrest cell growth, 
survival, and death (Hannun et al. 2001; Mathias et al. 1998). In contrast to 
ceramides those ceramide metabolites contain a hydrophilic region such as 
phosphate in the case of sphingosine-1-phosphate (S1P) and 
ceramide-1-phosphate as well as the phosphorylcholin in sphingomyelin. 
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Phosphorylation of the ceramide is catalyzed by ceramide kinase (Hannun et 
al. 2001; Mathias et al. 1998), while deacylation occurs by either neutral or 
acid ceramidase yielding sphingosine, which may be phosphorylated by 
sphingosine kinase to S1P by the so far two known sphingosine kinases, 
which differ in temporal patterns of appearance during development, are 
expressed in different tissues, and possess distinct kinetic properties (Liu et al. 
2000). 
While ceramide is often antiproliferative and proapoptotic, S1P plays a role in 
cellular proliferation and survival (Olivera and Spiegel 1993), and in protection 
against ceramide-mediated apoptosis (Cuvillier et al. 1996). A growing body of 
evidence is starting to point toward roles for ceramide generated through the 
salvage pathway in many biological responses, such as growth arrest 
(Ogretmen et al. 2002), apoptosis (Takeda et al. 2006), cellular signaling 
(Kitatani et al. 2006), and trafficking (Becker et al. 2005; Kitatani et al. 2006) 
Sphingosine itself has been proposed to induce apoptosis (Cuvillier 2002; 
Cuvillier et al. 2000; Cuvillier et al. 2001) independent of ceramide. 
However, it has been recently shown that ceramide induces autophagy in 
mammalian cells and that ceramide might kill mammalian cells by limiting 
cellular access to extracellular nutrients. Edinger et al. have found that 
ceramide starves cells to death subsequent to profound nutrient transporter 
down-regulation. In mammalian cells, a lethal dose of ceramide triggers a 
bioenergetic crisis by so severely limiting cellular access to extracellular 
nutrients that autophagy is insufficient to meet the metabolic demands of the 
cell (Edinger 2009; Guenther et al. 2008).  
As described above ceramide may be formed by several pathways, but the 
only way to degrade ceramide into sphingosine is through the activity of 
different ceramidases. These enzymes display a non peptide-specific amidase 
activity and are divided into three different species, an alkaline, a neutral, and 
an acid ceramidase. The best-characterized form is the human acid 
Introduction 
ceramidase. Human acid Ceramidase (N-Acetylsphingosine amidohydrolase, 
EC 3.5.1.23) catalyzes the hydrolysis of ceramide to sphingosine and free fatty 
acid (Fig. 1-4). 
 
O
OH
NH
HO
Ceramide
OH
NH2
HO
O
HO
Sphingosine
Fatty acid
Sap-D
+
Acid ceramidase
 
Fig. 1-4: The acid ceramidase catalyzes the hydrolysis of the amide-bond in ceramide 
with the presence of the sphingolipid activator proteins, Sap-D. 
 
Its deficiency or defect in humans results in Farber’s disease (Bär et al. 2001; 
Farber 1952; Zhang et al. 2000), a sphingolipidosis with accumulation of 
ceramide in various tissues, including liver, lung, and spleen. The phenotype of 
this rare sphingolipid storage disease is mainly attributed to deformed joints 
and skin lipogranulomatosis with subcutaneous nodules.  
Besides the sequencing and mapping of the gene (Li et al. 1999), the 
full-length cDNA encoding 395 amino acids was isolated (Koch et al. 1996). In 
addition, extensive cloning approaches as well as many genome projects led 
to the discovery and isolation of mouse (Li et al. 1998), rat (Mitsutake et al. 
2001), Drosophila (Yoshimura et al. 2002), and bacterial ceramidases 
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displaying an acidic pH optimum. Likewise, ceramidases with neutral and 
alkaline pH optima have been discovered (Mao et al. 2001), which do not 
relate with the acidic forms in their primary amino acid structure indicating their 
distinct roles and subcellular locations. While one alkaline ceramidase have 
been shown to be highly expressed in the skin (Mao et al. 2003), another 
distinct alkaline ceramidase possesses a substrate specificity to 
phytoceramide (Mao et al. 2001). There are also distinct forms of the neutral 
ceramidases. Thus, one form is a type II integral membrane protein that can be 
cleaved to reveal a secreted isoform (Tani et al. 2003) and expresses its main 
function in the digestion of the dietary sphingolipids in the gut (Kono 2006), 
while another is located to mitochondria (Kono et al 2006, el Bawab 2000). 
One form of the neutral ceramidases is located to the mitochondria , where it is 
breaks down ceramide to sphingosine (Bionda et al. 2004; El Bawab et al. 
2000). In addition, mitochondria contain enzymes capable of generating 
ceramide (ceramide synthase and reverse ceramidase) and several apoptotic 
stimuli have been shown to cause an elevation of mitochondrial ceramide that 
precedes the mitochondrial phase of apoptosis (Raisova et al. 2000). It is 
assumed that ceramides form oligomeric barrel-stave channels in planar 
phospholipid membranes (Siskind et al. 2003). In mitochondrial outer 
membranes, ceramide channels allow the release of proteins up to 60 kDa in 
size (Siskind et al. 2002). 
Acid ceramidase was first enriched in 1963 by Gatt and colleagues, but first 
purified to homogeneity from human urine in 1995 (Bernardo et al. 1995) and 
from placenta in 2000 (Linke et al. 2000). 
Human acid ceramidase is expressed as a 55 kDa protein, which is maturated 
in the secretory pathway. (Fig. 1-5) After internalization into the ER the 
N-terminal signal peptide is removed yielding the 53 kDa enzymatically 
inactive precursor form, which is glycosylated and transported via the 
mannose-6-phosphate receptor pathway to the endosomal/ lysosomal  
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Fig. 1-5: Schematic illustration of the acid ceramidase processing, adapted from (Bär 
et al. 2001). 
 
compartments, where it is processed into its active form (Ferlinz et al. 2001). 
The mature active form of human acid ceramidase is generated by the 
cleavage of the precursor protein to yield a heterodimer consisting of two 
different subunits α (MW: ~13kDa) and β (MW: ~40kDa) within the endosomal/ 
lysosomal pathway and deglycosylation of purified human acid ceramidase 
with endoglycosidase H or peptide-N-glycanase F reduces the molecular 
weight of the β-subunit to approximately ~30-35 kDa and to ~27 kDa, 
respectively (Linke 2000). The cleavage site was reported to be Ile-142 – 
Cys-143 (Ferlinz et al. 2001; Schulze et al. 2007) revealing the unglycosylated 
α-subunit (molecular mass, 13 kDa) and glycosylated β-subunit (40 kDa; 
peptide backbone, 28 kDa). Both subunits are linked by a single disulfide 
bridge (Schulze et al. 2007).(Fig. 1-6) 
. 
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Fig. 1-6: Disulfide pattern derived from mass spectrometry according to Schulze et al., 
2007. 
 
Mass spectrometry on tryptic and chymotryptic digest of recombinant acid 
ceramidase located this disulfide bridge. Studies, with recombinant human 
acid ceramidase overexpressed in Sf9 insect cells have shown that this 
cleavage and the conversion into the heterodimer also occur in vitro after 
acidification of the Sf9 culture medium to pH 4-5. Some lysosomal enzymes 
such as lysosomal N-acylethanolamine hydrolyzing acid amidase (NAAA), 
cathepsin L, and tripeptidyl-peptidase I were also reported to be subjected to in 
vitro processing under acidic conditions and activated by the cleavage. Further, 
the mass spectrometry apprpoach revealed a detailed mapping of the other 
disulfide bridges and the glycosylation patterns.  Human acid ceramidase has 
six potential N-glycosylation sites, five of which were reported to be actually 
glycosylated by complex glycostructures (Ferlinz et al. 2001; Schulze et al. 
2007). 
 
1.6 Ntn (N-terminal nucleophile)-Hydrolase 
Recently, it was shown that acid ceramidase exhibits 33–35% amino acid 
identity to the lysosomal N-acylethanolamine hydrolyzing acid amidase 
(NAAA), an amidase specific for N-palmitoyllethanolamine and other linear 
N-acylethanolamines and anandamides.  
The conspicuous sequence similarity of between human acid ceramidase and 
human NAAA as well as the homology of the N-terminal sequence to NAAA 
(Tsuboi et al. 2007), the bile salt hydrolase (BSH) (Rossocha et al. 2005) and 
penicillin V acylase (PVA) suggested that the ceramidase would belong to the 
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choloylglycine hydrolase family (Pfam PF02275), a subfamily of the N-terminal 
nucleophile (Ntn) hydrolase superfamily. The Ntn-hydrolases display a wide 
range of substrate specificity and resemble enzymes besides the ones 
mentioned above as diverse as the proteasome subunits (Bochtler et al. 1999; 
Seemuller et al. 1996), the lysosomal aspartyl glucosaminidase, the glutamine 
PRPP amidotransferase, and the fatty acid amide hydrolase (FAAH).  
 
Despite their insignificant homology in the primary structure, they share highly 
conserved motifs such as the N-terminus and other residues involve in the 
catalytic center and show an overall high similarity in the tertiary four-layered 
αββα sandwich structure and quarternary tetrameric structure (Rossocha et al. 
2005). They all catalyze the hydrolysis of amide bonds present in proteins and 
other amides such as lipids, bile salts, and other small molecules. They also 
share similar self-activation and catalytic mechanisms (Brannigan et al. 1995; 
Oinonen and Rouvinen 2000). Usually, Ntn-hydrolases are synthesized as 
pre-proteins, which are endoproteolytically processed to their active form. This 
process is autocatalytic generating an N-terminal residue, which is acting as a 
nucleophile.  For NAAA, BSH, and PVA, a cysteine has been shown to be the 
first residue of the mature protein. Crystal structures of BSH, PVA, and others 
members of this family have proven that this residue is central to the 
mechanism of catalysis and serves both as a nucleophile and as a proton 
donor (Kumar et al. 2006; Rossocha et al. 2005). The N-terminal amino group 
acts as the proton acceptor and activates the nucleophilic thiol group of the 
Cys side chain. The N-terminal cysteine becomes a catalytic center only upon 
removal of the initiation formylmethionine. Such unmasking post-translational 
modifications are common to all members of the Ntn hydrolase superfamily. 
Furthermore, Ntn-hydrolases, they all catalyze the amide bond hydrolysis, but 
they differ in their substrate specificities. The catalytic machinery is located in 
the structures in a similar manner: the N-terminal residue of Ntn-hydrolase 
Introduction 
functions as a nucleophile and as a catalytic base (Fig. 1-7). The reactivity of 
this nucleophile is affected by the amino acid residues interacting in the vicinity. 
During the reaction, a covalent intermediate is formed via a transition state, 
which is stabilized by residues from the oxyanion hole (Peräkylä et al 1997). 
The importance of the Cys -SH group was confirmed by mutagenesis that 
replacement of Cys with other potential nucleophilic residues such as Ser or 
Thr resulted in the loss of BSH activity. The removal or exchange of the 
nucleophilic residues by Ala, Ser, or Thr resulted in the loss of activity as it has 
been shown for BSH and NAAA. 
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Fig. 1-7: Catalytic mechanism of Ntn-hydrolases: Y represents oxygen or sulfur, and X 
represents nitrogen or oxygen. The reaction begins when the nucleophilic 
oxygen/sulfur of Thr/Ser/Cys donates its proton to its own α-amino group and attacks 
the carbonyl carbon of the substrate. The negatively charged tetrahedral intermediate 
is stabilized by hydrogen bonding (oxyanion hole formers). The acylation step is 
complete when the α-amino group of the Thr/Ser/Cys donates the proton to the 
nitrogen of the scissile peptide bond. The covalent bond between the part of the 
substrate and the enzyme is formed and the part of the substrate is released. The 
deacylation step begins when the hydroxyl group of water attacks the carbonyl carbon 
of the acyl-enzyme product, and the basic α-amino group of the nucleophile accepts 
the proton from the water molecule. The negatively charged intermediate is stabilized, 
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as in the acylation step. The reaction is complete when the α-amino group donates 
the proton to the nucleophile. Adapted from (Oinonen and Rouvinen 2000) 
 
1.7 Objective 
Human acid ceramidase hydrolyzes the sphingolipid, ceramide, into 
sphingosine and free fatty acid. The mature acid ceramidase consists of two 
subunits, which were derived from a single precursor by proteolytic processing. 
However, the mechanism of acid ceramidase precursor cleavage remains 
unclear. In addition, PSI-BLAST search (Altschul et al. 1997) for the acid 
ceramidase sequence revealed high homology with the N-terminal nucleophile 
(Ntn) hydrolase. For example, acid ceramidase exhibits 33–35% amino acid 
identity to the lysosomal N-acylethanolamine hydrolyzing acid amidase 
(NAAA), the conspicuous sequence similarity between human acid 
ceramidase and human NAAA as well as the homology of the N-terminal 
sequence to NAAA (Tsuboi et al. 2007), the bile salt hydrolase (BSH) (Jones et 
al. 2008), and penicillin V acylase (PVA) suggested that the ceramidase would 
belong to the choloylglycine hydrolase family. For NAAA, BSH, and PVA, a 
cysteine has been shown to be the first residue of the mature protein, which is 
acting as a nucleophile. Crystal structures of BSH, PVA, and others members 
of this family have proven that this Cys residue is central to the mechanism of 
catalysis and serves both as a nucleophile and as a proton donor (Kumar et al. 
2006); (Chandra et al. 2005). 
Therefore, to prove whether the ceramidase belongs to the same family further 
analyses will be necessary to clarify the physiological significance of the 
cleavage of ceramidase. For this purpose, we established the recombinant 
expression and purification of the human acid ceramidase precursor to further 
study the structure by crystallization and the function of its variants comprising 
mutations of the Cys 143 residue, known as the N-terminal residue of the 
β-subunit, and mutation of the amino acids next to the cleavage site. 
Introduction 
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It has been shown that saposin D is involved in vivo in ceramide hydrolysis by 
acid ceramidase (Linke et al. 2001), but it is still unclear whether Sap D and 
acid ceramidase have in vivo protein-protein interaction or affinity domains. 
The goal is to prove for this interaction using in vivo and in vitro cross-linking 
experimentsl between Sap D and acid ceramidase. 
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2 Results 
2.1 Functional expression of recombinant fusion protein “SEAP- 
haCerase” 
2.1.1 Generating the Recombinant Vector containing “SEAP-haCerase” 
One of the main goal of this thesis was the expression of recombinant human 
acid ceramidase precursor in insect cells (Sf9) to yield sufficient amounts of 
homogeneous and monospecific enzyme for biophysical and for structural 
investigations. For these experiments the Bac-to-Bac® Baculovirus 
Expression System is designed to create a recombinant baculovirus for 
high-level expression of the gene of interest in insect cells (Invitrogen). We 
have already expressed human acid ceramidase in insect cells (Schulze et al. 
2007), but following this procedure, we could not isolate pure precursor, due to 
the premature maturation of the ceramidase precursor already in the media, 
which may be triggered by mature ceramidase released from virus lyzed cells. 
Therefore, a new strategy must have been designed. We constructed the 
recombinant pFastBac Vector containing fusion DNA fragment of 
“SEAP-haCeramidase” (Fig. 2-1).  
 
Results 
 
 
Fig. 2-1: PCR amplify our fragments of choice using designed primer and construct 
the pFastBac plasmid including the gene “SEAP-haCeramidase” 
 
 
Due to the help of the secretory alkaline phosphatase (SEAP), which is only 
secreted into the medium, ceramidase will not occur in the lysosomes and 
maturation should be prevented. Sf9 cells infected with the recombinant 
baculovirus quickly secret a fusion protein “SEAP-haCerase” into the medium. 
Besides the SEAP secretion sequence the ceramidase DNA lacking its own 
ER-signal sequence also will contain a C-terminal His6-tag for affinity 
purification and two Tev –sites for the recognition of a Tev-protease, a 
protease from the Tobacco etch virus, which will later be used for the removal 
of SEAP and the His-tag. Once the recombinant fusion protein is digested with 
Tev protease, the pure haCeramidase precursor will be isolated (Fig. 2-2). 
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Fig. 2-2: After Tev protease digestion should haCeramidase precursor be obtained. 
Tev: a recognition sequence for tabacco etch virus (TEV) protease. His 6: allows 
purification of recombinant protein using Ni-NTA resin. 
 
 
After PCR amplification of the ceramidase cDNA and the SEAP cDNA (see for 
primers and protocols in the Materials and Method section), restriction enzyme 
digestion and ligation of the insert DNA fragments, the recombinant fusion 
DNA fragment was inserted into the pFastBac™ vector, which is a baculavirus 
transfer vector. The successful cloning was confirmed by restriction-enzyme 
analysis to verify the presence of DNA fragment “SEAP-haCeramidase” 
already in the pFastBac™ vectors (Fig.2-3) and sequencing (Seqlab GmbH). 
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Fig. 2.3: After restriction enzyme digestion digested SEAP-ceramidase pFastBac 
clones were analyzed by agarose gel electrophoresis. Lane 1.: the recombinant 
pFastBac™ plasmid digested with Kpn I. Lane 2.: the same plasmid digested with 
Kpn I and Bam HI. Lane 3.: the same plasmid digested with Kpn I, Bam HI, and Sal I. 
 
According to the result of restriction-enzyme analysis, the recombinant 
pFastBac™ vector with the fusion DNA fragment “SEAP-haCerase”was 
successfully constructed. 
 
2.1.2 Expressing the recombinant fusion protein ”SEAP-haCerase” 
Based on a method developed by Luckow 1993, the Bac-to-Bac baculovirus 
expression system takes advantage of the site-specific transposition 
properties of the Tn7 transposon (Luckow et al. 1993), which recognition site is 
present on the pFastBac transfer vector and on the baculogenome and allows 
the insertion of the pFastBac insert, here the SEAP-ceramidase into the baculo 
genome. In the Bac-to-Bac system the transposition can be performed in 
recombinant E.coli containing the modified baculo genome. Once transposition 
reaction was performed, the high molecular weight recombinant 
baculogenome DNA (bacmid) will be isolated and then transfected the bacmid 
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DNA into insect cells to generate a recombinant baculovirus. After the 
baculoviral stock is amplified and titered, this high-titer stock can be used to 
infect insect cells for high-level expression of the recombinant fusion protein. 
This recombinant SEAP-ceramidase pFastBac™ vector was transformed into 
DH10Bac™ E. coli strain, which contained a baculovirus genome (bacmid) 
with a mini-attTn7 target site and a helper plasmid. Transposition occurs 
between the mini-Tn7 element on the pFastBac™ vector and the mini-attTn7 
target site on the bacmid to generate a recombinant bacmid containing the 
fusion DNA fragment “SEAP-haCerase”. This transposition reaction occurs in 
the presence of transposition proteins supplied by the helper plasmid. 
Subsequently, as described above, the isolated recombinant bacmid DNA was 
transfected into Sf9 cells to generate a baculovirus containing DNA fragment 
“SEAP-haCerase”. The high-titer virus-stock infected Sf9 cells again to 
express the recombinant fusion protein “SEAP-haCerase” (Fig.2-4). 
 
 
 
Fig. 2-4: Recombinant Bacmid DNA was transfected into insect cells to produce new 
recombinant baculovirus and then expression of recombinant fusioin protein 
“SEAP-haCerase”. 
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Once the baculoviral stock was generated, we used this new recombinant 
baculovirus to infect insect cells (Sf9) and analyzed the medium for the fusion 
protein “SEAP-haCerase”. Due to SEAP, the fusion protein was secreted into 
media, which was harvested 4 days post-infection (4-dpi). The identity of the 
fusion protein was ascertained by Western blot analysis with an anti-acid 
ceramidase rabbit antibody. SEAP-haCerase” was successfully synthesized 
as a 110 kDa fusion protein and Tev-protease digestion from the crude media 
revealed the cleavage from the fusion partners. However after 4-dpi there is 
still proteolytic cleavage of this protein into its heterodimeric mature form (40 
kDa β-subunit and 70 kDa SEAP-α-subunit).  
 
 
 
Fig. 2-5: (A.)Tev protease and Western blot analysis. Expression of the recombinant 
fusion protein in baculovirus-infected insect cells and then media was collected at 4 
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days. 30 µl samples were loaded onto 8% Tris/Tricine SDS-PAGE gel. Lane 1. the 
harvested media (4dpi) without Tev protease digestion, lane 2-4. time-course test with 
Tev protease. (B.) Illustration for proteolysis of fusion protein “SEAP-haCerase”. 
 
 
2.2 Functional expression of a series of site-directed mutant fusion 
protein ”SEAP-haCerase” 
 
2.2.1 Introducing point mutation into the acid ceramidase cDNA. 
So far, the recombinant fusion protein was synthesized as a monomeric 110 
kDa, but still a fast proteolytic process of this protein into heterodimeric units 
(40 kDa β-subunit and 70 kDa SEAP-α-subunit) occured in medium despite 
the help of the secretory alkaline phosphatase (SEAP). This was probably due 
to the fact that the proteolytic processing of acid ceramidase is occurring 
autocatalytically generating the N-terminal nucleophilic Cys of the β-subunit. 
Therefore, another new strategy for the expression of the acid ceramidase 
precursor had to be developed. We propose that proteolytic process of acid 
ceramidase should occur only under specific interaction among amino acids 
near cleavage site. To investigate this point, we make point mutations by 
mutating amino acids near the cleavage site to avoid proteolytic process of 
acid ceramidase.  
According to chapter 2.1.1 the recombinant SEAP-ceramidase pFastBac™ 
plasmid was used as a template for constructing mutant expression plasmids 
by polymerase chain reaction (PCR). The designed primers and their 
antisense primers (Materials and Methods) were synthesized to introduce 
point mutations into the acid ceramidase cDNA through the QuickChange 
site-directed mutagenesis kit from Stratagene. The final PCR products, newly 
synthesized mutant-acid ceramidase cDNA constructs, were confirmed by 
sequencing (Seqlab GmbH). (Fig. 2-6)  
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Fig. 2-6: Site-directed mutagenesis of amino acids near the cleavage site between α- 
and β-subunit of acid ceramidase.  
 
2.3 Expressing the mutant fusion protein ”SEAP-haCerase” 
The confirmed mutant plasmids were then transformed into DH10Bac™ E. coli 
strain competent cells containing the baculovirus genome to generate a 
recombinant mutant SEAP-ceramidase bacmid. Subsequently, as previously 
described, the isolated recombinant mutant SEAP-ceramidase bacmid DNA 
was transfected into Sf9 cells to generate a baculovirus containing the mutant 
DNA region. The high-titer virus-stock infected Sf9 cells again to express the 
mutant fusion protein “SEAP-haCerase”. We produced a series of recombinant 
viruses expressing point-mutant variants of the SEAP-ceramidase protein. All 
variants were expressed in Sf9 insect cells. After 72 hours, the infected Sf9 
cells were harvested by centrifugation (6000 rpm, 30 min). The supernatant 
including the mutant fusion proteins “SEAP-haCerase” was directly subjected 
to SDS-PAGE followed by Western Blot (Fig.2-7). 
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Fig. 2-7: Expressing a series of mutant fusion protein in baculovirus-infected Sf9 cells 
and then the culture supernatant was harvested at 3 days. 30 µl samples were loaded 
onto each lane of 8% Tris/Tricine SDS-PAGE gel and analyzed by Western blot. 
 
 
It became clear that only mutants of the nucleophilic Cys, Cys143Ala and 
Cys143Met, do not show any proteolytic cleavage, whereas all other variants 
were still cleaved. We verified the expression of the mutant Cys143Ala again 
to determinate, whether the mutation delayed or completely blocked acid 
ceramidase proteolytic processing. No increase in α- or β-subunit was 
observed (Fig.2-8).  
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Fig. 2-8: Western blot with acid ceramidase antibody under reducing condition. (A.) 
Expression of the variant fusion protein (Cys143Ala) in baculovirus-infected Sf9 cells. 
The culture supernatant was collected at 3, 4, and 5 days, respectively. (B.) The 
supernatant including mutant fusion protein was digested with Tev protease in 
time-course. 
 
 
Depending on this result, we assumed that Cys143, the N-terminal amino acid 
of the β-subunit of acid ceramidase, plays an important role in the maturation 
of acid ceramidase. Following this procedure, we can stop proteolytic 
processing of acid ceramidase, and then isolate a pure variant precursor of 
acid ceramidase for structural studies. 
 
2.4 Purification and characterization of acid ceramidase precursor 
2.4.1 Establishing the purification strategy for sufficient amounts of 
acid ceramidase precursor 
For preparative expression and purification of variant fusion protein 
(Cys143Ala), stably transformed Sf9 cells were cultured as 800 mL 
suspension cultures in 2 L flask to a final density of 2.2 x 106 cells/mL. Since 
the expression level reached an approximate plateau after 96 hours, at this 
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time point, the medium was harvested by centrifugation (6000 rpm, 30 min) 
and kept at 4°C. As Fig.2-9 showed, the supernatant was then concentrated 
10-fold by VivaFlow 200 (Vivascience) with filter-membrane 100,000 MW 
(PES), and then the concentrated medium was exchanged to 
DEAE-Sepharose equilibration buffer (50 mM Tris/HCl; 100 mM NaCl, pH 7.4) 
by dialysis overnight. The buffer-exchanged supernatant (200 ml) was then 
loaded onto DEAE-Sepharose (75 ml bed volume, Sigma) pre-equilibrated 
with washbuffer (50 mM Tris-HCl, 100 mM NaCl, pH 7.4). The suspension of 
flow-through was collected. After overnight dialysis with Ni-NTA washbuffer 
(50 mM NaH2PO4, 300 mM NaCl, 20 mM imidazole, pH 7.8), the suspension 
was clarified by centrifugation (10000 rpm, 30 min) and sterile filtration (0.2 
μm). The filtrate was loaded onto a Ni-NTA superflow column (15 ml bed 
volume, Qiagen). After the column was washed with 40 ml of Ni-NTA 
washbuffer, absorbed proteins were directly eluted in 20 ml of 50 mM 
NaH2PO4, 300 mM NaCl, 125 mM imidazole (pH 7.8) elution buffer. The eluted 
sample was then concentrated 5-fold by Vivaspin 20 concentrater 
(Vivascience) with filter-membrane 100,000 MW (PES), 2000 rpm, and then 
the concentrated sample (final volume:~2 ml) was loaded onto gel fitration 
column: Superdex 75 Hiload 16/60 in FPLC system. Pooled fusion protein 
“SEAP-haCerasemut” fractions (Number:14~19.) were concentrated (final 
volume: ~2 ml) and buffer exchange with Tev-buffer (50 mM Tris/HCl, pH 7.6, 
0.5 mM EDTA, 1 mM DTT) using Vivaspin 20 (Vivascience). Tev protease 
cleavage reaction was performed three hours at room temperature (Invitrogen). 
The digested sample was loaded again onto the same gel fitration column: 
Superdex 75 Hiload 16/60 in FPLC system. The newly appearing peak 
fractions were collected, resulting only in the purified enzyme ”haCerase” 
without SEAP and 6x histidine amino acids. 
 
Results 
 
 
Fig. 2-9: Schematic illustration of the acid ceramidase precursor purification steps.  
 
The purified precursor revealed a pure protein band around ~53 kDa as 
analyzed by SDS-PAGE followed by silver-staining. (Fig.2-10) and protein 
sequencing (Toplab GmbH). The purified acid ceramidase precursor (~80 μg 
pro liter culture medium) is currently used in crystallization experiments. 
 
 
 
32
Results 
 
Fig. 2-10: Gel filtration: superdex 75 chromatography of fusion 
protein ”SEAP-haCerasemut” and then SDS-PAGE analysis. 30 µl of each fraction 
were loaded onto 8% Tris/Tricine SDS-PAGE under reducing condition. Proteins were 
then visualized by silver staining. (A.): The first running of gel filtration without Tev 
protease reaction. (B.): The second running of gel filtration after Tev protease 
digestion. 
 
2.4.2 Activity analysis of acid ceramidase precursor 
To further examine the influence of amino acid substitution (Cys143Ala) on 
ceramide-hydrolyzing activity of recombinant human acid ceramidase, both 
wild-type mature form and precursor (Cys143Ala) were allowed to react with 
N-lauroyl-sphingosine (C12-ceramide) in a micellar, detergent-based assay 
system (Bernardo et al., 1995). (Fig.2-11). Compared to wild-type the 
precursor (C143A) ceramidase had almost no activity, suggesting that Cys143 
residue was also important for ceramide hydrolysis. 
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Fig. 2-11: Effect of Cys143Ala mutation on acid ceramidase activity. 
 
2.5 Investigating the function of Cys143 in precursor processing 
mechanism 
2.5.1 Inhibition studies of acid ceramidase proteolytic processing with 
p-chloromercuribenzoic acid 
It has been shown that NAAA as described in the Introduction show similar 
processing activites as the ceramidase. When incubated at pH 4.5, the 48-kDa 
form of NAAA was time-dependently converted to the 30-kDa form with 
concomitant increase in the N-palmitoylethanolamine-hydrolyzing activity. The 
purified 48-kDa form was also cleaved and activated. However, the cleavage 
did not proceed at pH 7.4 or in the presence of p-chloromercuribenzoic acid 
(PCMB). The mutant Cys126Ser was resistant to the cleavage and remained 
inactive. These results suggested that this specific proteolysis is a 
self-catalyzed activation step.  
 
 
34
Results 
 
 
35
It can be assumed that acid ceramidase catalyzes a similar reaction sequence 
at pH 4.0. The active center of acid ceramidase must therefore provide a 
nucleophile that reacts with the acyl carbon, an "oxyanion hole" that stabilizes 
the tetrahedral intermediate and an acid-base pair that transfers a proton to 
the leaving group sphingosine.  
In order to find out which types of amino acids are possibly involved in 
ceramide degradation, acid ceramidase was incubated with a number of 
different group-specific inhibitors at pH 4.0 in previous studies of T. Linke 
(Linke 2000). Residual pAC activity was determined in a micellar assay system. 
The table shows that low concentrations of inhibitors directed toward cysteine 
and methionine dramatically decreased ceramidase activity activity.  
 
 Concentration (μM) 
Residual enzymatic activity 
(in % of control) 
Inhibitor Specificity 0 1 10 100 
Thimerosal Cysteine, 100 60 12 8 
Iodoacetamide Cysteine, 
Methionine 
100 10 9 6 
Phenylmethylsulfonyl
fluorid (PMSF) 
Serine 100 94 90 80 
Ethyldiisopropylcarbo
diimid (EDC) 
Aspartate, 
Glutamate 
100 60 25 10 
Diethylpyrocarbonate 
(DPC) 
Histidine 100 90 50 12 
*Ceramide degradation was measured with purified protein in a detergent-containing, 
micellar assay system (From (Linke 2000)) 
 
The effect of the reducing agents, DTT and TCEP, were also tested at pH 4.0. 
Unexpectedly, treatment of ceramidase with TCEP at pH 4.0 increased 
enzymatic activity 3-fold, treatment with DTT at pH 4.0 1.5-fold (Linke 2000). 
Results 
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However, it is not clear whether this increase was due to a reduction of 
disulfide bonds. It is conceivable that other amino acids such as methionine or 
cystein became oxidised during the purification procedure of acid ceramidase. 
(Linke 2000) 
In analogy to NAAA we already know that Cys143-substitution can not only 
stop the processing of the acid ceramidase precursor into mature form but also 
block the activity of acid ceramidase enzyme, suggesting that Cys143 residue 
was important. This result raises an interesting question as to whether Cys143 
from (wild-type) acid ceramidase is free for enzymatic reaction or it is only 
involved in a disulfide-bridge for structural stabilization proposed by (Schulze 
et al. 2007). In this regard, it will be of particular interest to determine whether 
Cys143 can be modified by chemical cross-linker p-chloromercuribenzoic acid 
(pCMB). p-chloromercuribenzoic acid (pCMB) is an organic mecurial used as a 
sulfhydryl reagent. If Cys143 is indeed free and not involved in a disulfide 
bridge, it’s thiol group could supposedly be modified with pCMB. Subsequently, 
as previously described, if Cys143 is modified, proteolytic processing of acid 
ceramidase should be prevented. According to this supposition, the Sf9 cells 
suspension culture were treated with pCMB (final conc. 1mM) after 3 days of 
infection Fig.2-11 Western blotting analysis further revealed that wild-type 
fusion protein “SEAP-haCerase” with 1 mM pCMB completely inhibited 
processing of acid ceramidase. After pCMB was added to the infected Sf9 
cells suspension culture including acid ceramidase, maturation of the 
ceramidase into α- and β- subunits was prevented and only the processing 
product, which was already present before the pCMB treatment, was detected.  
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Fig. 2-11: Inhibition of acid ceramidase proteolytic processing with pCMB. (A.) As 
control: without pCMB treatment in infected Sf9 cell suspension. (B.) After 3 days 
infection, the infected Sf9 cell suspension was treated with/without pCMB. Expressing 
wild-type fusion protein in baculovirus-infected Sf9 cells and then the culture 
supernatant was collected at 3, 4, and 5 days, respectively, and analyzed by 
SDS-PAGE followed by Western blot using acid ceramidase antibody.  
 
 
2.5.2 Identifying Cys143 of acid ceramidase as marked residue by pCMB  
pCMB prevented the processing of the ceramidase precursor into its mature 
form. Cys143 should contain a free thiol function, which could be labeled by 
pCMB. For further determination, whether Cys143 of acid ceramidase was 
labeled with pCMB, the treated acid ceramidase was “In-gel” digested with 
trypsin protease and the resulting products were analyzed by MALDI-MS for 
peptide containing modified or not modified Cys residue. 
The In-gel digestion protocol was originally introduced in 1996 by Shevchenko 
et al. (Shevchenko et al. 2006), and has been used thousands of times over 
the last 10 years. The In-gel digestion procedure is compatible with 
down-stream mass characterization of digests of isolated protein band. 
MALDI-MS Identification of proteins from In-gel digestion offers some 
important advantages compared to In-solution digestion. For example, gel 
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electrophoresis removes low molecular weight impurities, including detergents 
and buffer components, which are often detrimental for mass spectrometric 
sequencing. Use of pure protein (single band) for mass spectrometric analysis, 
decreases a significant background noise of digested products. 
The pCMB-treated Sf9 cell culture supernatant was harvested 4 days 
post-infection, acid ceramidase was then purified. After first gel-filtration 
column: superdex-75 purification step, the concentrated sample (~0.8 mg) was 
loaded onto 8% Tris/Tricine SDS-PAGE under reducing condition, excising the 
band of fusion protein “SEAP-haCerase”, In-gel trypsin digestion according to 
manufacture’s protocol (Andrej et al., 2007), prior to MALDI-MS identification 
of peptide containing pCMB labeled Cys143. To analyze the result of In-gel 
trypsin digestion, Fig.2-12 shows the tryptic peptides of the acid ceramidase 
precursor after trypsin digestion. 
 
 
 
Fig. 2-12: Amino acid sequence of the acid ceramidase precursor. Tryptic cleavage 
sites are indicated by gaps, tryptic peptides are named T und numbered from 1 to 39. 
Cysteine residue was labeled in red (Adapted from (Schulze et al. 2007)) The tryptic 
cleavage pattern was generated using the Swissprot database. 
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The resulting In gel digestion peptides were identified as tryptic peptides by 
their mass. Based on Fig.2-12, instead of the wild-type Cys143-peptide “T12” 
with a mass of 3704 Da, the mass of mutant Cys143Ala-peptide “T12” should 
be 3672 Da. The peptide containing the pCMB-labeled Cys143 residue has a 
mass that is increased by 322 Da (mass of pCMB) compared to the untreated 
Cys143-peptide. As shown in Fig.2-13 in the MALDI spectrum detected 
peptides, we did not find any significant peak corresponding to untreated 
Cys143- or pCMB-labeled tryptic peptide “T12”. Excluding peptide recovery 
from gel as shown above, the main reason for this may be that long peptide 
still remains trapped in the gel due to poor diffusion or the crosslinkt peptide is 
not sufficiently digested. 
 
 
A. 
Peptide “T12”: 3672 Da  
calculated mass: 
untreated mutant precursor: 
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B. 
pCMB-labeled “T12”: 4026 Da 
calculated mass: 
unlabeled peptide “T12”: 3704 Da 
pCMB-treated wild-type acid ceramidase: 
 
Fig. 2-13: MALDI Mass spectrum of the tryptic digest and the corresponding inset 
zoom scan of the Cys143-peptide “T12”. (A.) Untreated mutant fusion protein 
“SEAP-haCerase”. (B.) pCMB treated wild-type fusion protein “SEAP-haCerase”. 
 
 
Unfortunately, there is no direct evidence to demonstrate whether the Cys143 
residue is free, but some indirect data were still obtained from MALDI-MS 
analysis. Perhaps due to better diffusion efficiency of small peptides from gel, 
MALDI Mass spectrometry resulted in high yield of small peptides that 
occurred after In gel trypsin digestion. According to the previous published 
results (Schulze, 2007), there is a disulfide bond that occurred between 
Cys143 and Cys292. If Cys143 of acid ceramidase was free, the other 
cysteine residue: Cys292 of acid ceramidase should be also in a free state. 
Base on Fig.2.12, the tryptic peptide containing Cys292 is “T25” peptide that 
has a mass of 2280 Da. On the other hand, the peptide containing the 
pCMB-labeled Cys292 residue should have a mass that is increased by 322 
Da to the mass of 2602 Da. As shown in Fig.2-14. (B.), after pCMB treatment 
of the wild-type SEAP ceramidase fusion protein the spectrum showed that the 
peptide corresponding to the Cys292-peptide “T25” has a significant decrease 
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in the peak compared to untreated fusion protein. At the same time, a new 
signal was obtained. However, the signal for this peptide corresponding to the 
correct mass was weak, but detectable. Therefore, Cys292 residue should be 
probably at least partially in a free state. According to this indirect evidence 
above, the Cys143 residue should be also in a free state. 
 
 
 
 
Fig. 2-14: MALDI Mass spectrum of the corresponding inset zoom scan of the 
Cys292-peptide “T25” and some of the other tryptic peptides from acid ceramidase. 
(A.) Untreated mutant fusion protein “SEAP-haCerase”. (B.) pCMB treated wild-type 
fusion protein “SEAP-haCerase”. 
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2.6 Cross-linking experiment between acid ceramidase and saposin D 
The ceramide hydrolysis by acid ceramidase in vivo requires the presence of 
saposin D (Klein et al. 1994), but it is still unclear whether Sap D and acid 
ceramidase have in vivo protein-protein interaction domains. In order to 
demonstrate whether a binding or affinity domain between acid ceramidase 
and Sap D exists, cross-linking interaction experiments in cells between Sap-D 
and acid ceramidase were studied. 
 
2.6.1 In vivo cross-linking experiment 
Cross-linking is a useful tool in the study of protein-protein reactions, but the 
nature of most cross-linking methods prevents their use in live cells. Recently, 
the use of photo-reactive amino acid analogs to create cross-links between 
interacting proteins has allowed to study protein complexes in vivo. Analogs of 
leucine and methionine, both featuring photosensitive diazirine rings, are fed to 
growing cells. These analogs are incorporated into proteins and create 
cross-links between interacting proteins when exposed to ultraviolet light. 
Photo-sensitizers undergo photo-excitation with exposure to light, transferring 
energy to reactions. The photo-excited molecules are generally very reactive 
as well, frequently binding readily to nearby compounds. The amino acid 
analogs, such as the one used in the following experiments, take advantage of 
the reactivity of photo-excited molecules. The analogs are identical to the 
natural amino acids, except for a photosensitive diazirine ring. When exposed 
to UV light, the nitrogen is released and a reactive carbene is formed.  
The activated carbene has a very short half-life, so reactions must occur with 
groups in a very close proximity. In a protein complex, the carbenes will react 
with nearby groups to form stable cross-links that “freeze” the complex in its 
current position, allowing to analyze the protein-protein interactions within the 
complex. 
Results 
L-photo-leucine is an analog of L-leucine amino acid. It contains a diazirine 
ring for crosslinking with ultraviolet light (UV) and can substitute in vivo natural 
amino acid (L-leucine) into primary sequence of proteins during synthesis 
(Fig.2-15).  
OH
O
H
H2N
N
N
OH
O
H
H2N
L-Photo-Leucine L-Leucine
 
Fig.2-15: Structure of L-Photo-Leucine containing a diazirine cross-linking unit and it’s 
natural analog. 
 
The photoleucine is used in combination with Dulbecco’s Modified Eagle’s 
limiting media that is devoid of leucine and methionine, As a result, 
L-photo-leucine can be substituted for leucine in the primary sequence of 
proteins. Crosslinked protein complexes can then be detected by running 
SDS-PAGE followed by Western blot (Fig.2-16).  
 
Analyze by Western blot Add photo-leu Expose cells to UV 
 
 
ig.2-16: Protocol summary for protein interaction experiments with L-Photo-Leucine 
o probe for for interaction of acid ceramidase and Sap-D with photo-leucine, 
F
in baby hamster kidney (BHK) cells. 
 
T
different cell lines such as HeLa cells, human primary fibroblasts and baby 
hamster kidney cells (BHK) overexpressing prosaposin or Sap-precursor, were 
incubated with the leucine deficient medium. The cells were incubated for 24h 
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n Fig.2-17, the result suggests that the same band (as red arrow 
 
 
Fig.2-17: Direct protein interaction analysis of the in vivo crosslinking experiments of 
and the medium was discarded. The cells were washed with PBS and 
irradiated with UV light, they were harvested and lyzed in RIPA buffer. 
Likewise, the same set of cells treated with 1% paraformaldehyde (PFA) for 30 
min for PFA-crosslinking. The cells were harvested and also lyzed in RIPA 
buffer. Eventually, the lysates were analyzed by SDS-PAGE and 
simultaneaous Western blots with goat anti-Sap-D and rabbit anti-ceramidase 
antibodies 
As shown i
between 83 and 62 kDa) was detected both with Sap-D and acid ceramidase 
antibody. Further analyses suggested the interaction site within the α-subunit 
of the ceramidase. However these results need to be verified by other 
crosslink experiments 
acid ceramidase and Sap D. BHK cells lysates (10 μg) were loaded onto each lane of 
8% SDS-PAGE followed by western blot to detect cross-links with Sap D antibody or 
Ceramidase antibody. Lane1: purified Sap D as control. Lane2: standard protein 
marker. Lane3, 6: cells were treated with photo-leucine followed by UV treatment. 
Lane4, 5: cells were untreated. Lane7: cells were treated with 1% paraformaldehyde 
(PFA) on ice for 30 min. 
Results 
2.6.2 In vitro cross-linking experiment 
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 crosslink experiments with 
purified acid ceramidase and Sap-D were performed. Here we used a very 
In analogy to the in vivo experiments, in vitro
common bifunctional crosslink reagent. DSG (Disuccinimidyl glutarate) 
(Fig.2-18) is a homobifunctional N-hydroxysuccinimide ester (NHS-ester). 
Primary amine from lysine side chains is a principal target for NHS-esters. A 
covalent amide bond is formed when the DSG reacts with primary amines of 
protein. This cross-linker is noncleavable, even when analyzed by SDS PAGE 
under reducing condition. 
 
 
Fig.2-18: Structure of DSG. 
 
The purified wild-type and mature acid ceramidase and purified unglycosylated 
ed in reaction buffer followed by treatment with recombinant Sap-D were mix
DSG. After SDS-PAGE the crosslinked mixture was analyzed by Western blot 
using rabbit anti-acid ceramidase antibody or goat anti-Sap D antibody, as 
shown in Fig.2-19. The experiment revealed the cross-link product band at the 
same molecular weight (between 83 and 62 kDa) as found in the in vivo 
cross-linking test. The predicted molecular weight of a cross-link between one 
monomer of Sap-D and one monomer of ceramidase would be around 65 kDa. 
As there are also cross-link bands around 120 kDa one would assume an 
interaction between Sap-D dimer and a ceramidase dimer. The mass 
spectrometry of these cross-link products is ongoing and so far we cannot 
predict the correct composition of these bands.  
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Fig. 2-19: The purified protein interaction test in vitro between acid c  
s shown in Fig. 2-20, unglycosylated Sap-D from recombinant expression 
eramidase and
Sap D. After DSG treatment at room temperature for 30 min, or in the absence of 
DSG, the samples (20 μl) were analyzed by SDS-PAGE followed by western blot to 
detect cross-links with ceramidase antibody or Sap D antibody. Lane1: Only purified 
acid ceramidase untreated with DSG. Lane2, 3: acid ceramidase and Sap D protein 
mixture (1:1) treated with DSG. Lane4: acid ceramidase and Sap D protein mixture 
(1:2) treated with DSG. Lane5: acid ceramidase and Sap D protein mixture (1:1) not 
treated with DSG. Lane6: Purified Sap-D treated with DSG. 
 
A
could be mainly purified as a homodimer and a monomer. The same seems to 
be the case for the ceramidase in some experiments we could detect a 
cross-link product of an α-homodimer and a dimer of the mature ceramidase. 
Fig. 2-20 also shows Sap-D and ceramidase cross-link products in a range of 
about 62-150 kDa suggesting a cross-linking between monomers or dimers of 
both.  
Results 
 
Fig. 2-20: The purified protein interaction test in vitro between acid ceramidase and 
Sap D. After DSG treatment at room temperature for 30 min, or in the absence of 
DSG, the samples (20 µl) were analyzed by SDS-PAGE followed by western blot to 
detect cross-links with ceramidase antibody or Sap D antibody. Lane1: Acid 
ceramidase and Sap D protein mixture (1:2) treated with DSG. Detection with anti 
Sap-D antibody. Lane 2: Purified Sap-D treated with DSG Lane Detection with anti 
Sap-D antibody. Lane 3: Acid ceramidase and Sap D protein mixture (1:2) treated 
with DSG. Detection with anti ceramidase antibody. Lane4: Only purified acid 
ceramidase untreated with DSG. The cross-link products are assumed to correspond 
to the indicated protein forms. 
 
In a further experiment, the influence of lipids such as ceramide and 
bismonoacylglycerophosphate (BMP) on the binding of Sap-D and ceramidase 
was investigated (Fig. 2-21). Unfortunately, we could not detect any effects 
since the binding assay does not seem compatible with the cross-linking 
conditions. Sap-D seems to be dislocated from the ceramidase since no 
crosslink products can be detected. It can be assumed that Sap-D is depleted 
by the liposomes as it is unglycosylated and hydrophobic. 
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Fig. 2-21 DSG Cross-linking experiments of ceramidase and Sap-D in presence or 
absence of lipids. The detection was performed with anti-ceramidase antibody 
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3 Discussion 
3.1 Expression and Characterization of recombinant fusion protein 
“SEAP-haCeramidase” 
The main goal of this study was the expression of recombinant human acid 
ceramidase precursor in insect cells (Sf9) to yield sufficient amounts of 
homogeneous enzyme for biophysical and structural investigations. We have 
already expressed human acid ceramidase in insect cells (Schulze et al. 2007), 
but the separation of precursor and mature acid ceramidase obtained from the 
culture supernatant of the Sf9 cells was very difficult and could only be 
achieved under denaturating conditions. In order to generate the recombinant 
baculovirus expressing only the human acid ceramidase precursor, a fusion 
construct of secretory alkaline phosphatase (SEAP) - Tev cleavage site - acid 
ceramidase (preprotein) - Tev cleavage site – 6xHis tag was designed. With 
the help of SEAP, the infected Sf9 cells quickly secreted a fusion protein 
“SEAP-haCerase” into the medium to avoid proteolytic processing of acid 
ceramidase. For this purpose the different genetic building blocks were 
amplified in several PCRs. The PCR products: “SEAP-Tev” and 
“haCerase-Tev-6xHis” fragments were ligated into the pFastBac transfer 
vector. The recombinant plasmid was transposed into the baculo genome, 
which was used to generate a recombinant virus. Following the infection of Sf9 
cells with the recombinant virus “SEAP-haCerase” was successfully 
synthesized as a 110 kDa fusion protein. However, proteolytic processing into 
its heterodimeric mature form (40 kDa and 70 kDa) still occurred in the medium 
despite the help of SEAP, which should prevent the processing by only 
expressing the secreted ceramidase. 
 
 
 
Discussion 
3.2 Expression and Characterization of mutant fusion protein 
“SEAP-haCeramidase” 
Initially, we assumed that proteolytic processing of acid ceramidase would be 
achieved presumably by a lysosomal protease, which might be active in Sf9 
cell culture supernatant and was acting as a “substrate-proteinase” (Carrington 
et al. 1988). For example, the proteinase can require a specific sequence motif 
at the cleavage sites for correct recognition of the substrate. If the ceramidase 
cleavage motif would be changed, the proteolytical cleavage should be 
impaired. According to this supposition, we have made point mutations to alter 
the amino acids near the cleavage site to avoid proteolytic processing of acid 
ceramidase. 
Carrington et al. (1988) 
 
Seven mutants were engineered by substituting the residues with different 
amino acids (Thr141, Ile142val, Cys143Ala, Cys143Met, Thr144Ala, 
Ser145Ala, Ser145Thr). But the result did not correspond to our theory, as 
shown in Fig.2-7, It became clear that only the variant ceramidase, which 
contain an exchange of the nucleophilic Cys to Cys143Ala and Cys143Met is 
impaired in proteolytic cleavage, whereas all other variants were still cleaved. 
Therefore, proteolytic processing of acid ceramidase was assumed to occur 
autocatalytically into its α- and β- subunits, similar to other members of the 
N-terminal nucleophile (Ntn) hydrolase superfamily.  
As only the substitution of nucleophilic Cys143 does not show any proteolytic 
cleavage, we established the overexpression and purification of the variant 
Cys143Ala fusion protein to produce a large amount of acid ceramidase 
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precursor, in order to analyze the structure in crystallization experiments. By 
crystallographic studies of the precursor and the mature ceramidase, we can 
obtain detailed insights into the structures, catalytic center, and the complete 
cleavage mechanism of ceramidase. 
 
 
3.3 The investigation into the function of Cys143 in acid ceramidase 
As described above, the proteolytic processing of acid ceramidase seems to 
reveal an α- and a β- subunits. In addition, we already know that 
Cys143-substitution (be meant also as modification) can not only stop the 
processing of the acid ceramidase precursor into its mature form but also 
blocked the activity of acid ceramidase enzymatic function, suggesting that 
Cys143 residue plays a critical role in acid ceramidase activity. More 
importantly, using extensive sequence similarity searches (Altschul et al. 1997), 
acid ceramidase is homologous to lysosomal N-acylethanolamine hydrolyzing 
acid amidase (NAAA) and penicillin V acylases (PVA) (Tsuboi et al. 2007), 
which belong to the superfamily of N-terminal nucleophile (Ntn) hydrolases. 
According to these findings above, we propose that the acid ceramidase is 
also a member of Ntn-hydrolase superfamily . 
There are a total of 6 cysteine residues among the primary sequence of acid 
ceramidase, all of the 6 cysteines might be involved in 3 different disulfide 
bonds for structural stabilization (Schulze et al. 2007), but based on the good 
inhibititory effect of iodoacetamide (IAA), a cysteine protease inhibitor, on acid 
ceramidase (Linke, 2000) , we presumed that at least one of six cysteines 
residues could be involved in the catalytic center of acid ceramidase. If acid 
ceramidase belongs to superfamily of Ntn-hydrolases, after cleavage, the 
N-terminal nucleophilic Cys143 of the β-subunit should serve as the active site 
for ceramide hydrolysis. Therefore, the Cys143 residue must at least partially 
contain a free thiol group. Consequently, when Cys143 will be labeled by 
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sulfhydryl reagent pCMB, proteolytic processing of acid ceramidase should be 
prevented. As shown in Fig.2-11, we confirmed that Cys143 residue should be 
in a free state. Although a MALDI MS spectrum for further demonstration failed 
to detect the pCMB labeled freagment, we still found some indirect evidences 
to support our concept (Fig.2-15). In addition, a model of the tertiary structure 
of the acid ceramidase β-subunit using the crystal structure of cholylglycine 
hydrolase, one member of the Ntn hydrolases, as a template (Shtraizent et al. 
2008) revealed that Cys143 was too far from other cysteine residues, such as 
Cys292, to form a disulfide bond. According to the description above, we 
believe that Cys143 residue should contain at least partially a free thiol group 
not associated in a disulfide bond, which serves as catalytic site, although 
Schulze et published the existence of a disulfide bridge between Cys143 and 
Cys229 (Schulze et al., 2007). So far, we cannot exclude that to a partial 
extend such disulfide bridge exists or how much of the catalytic Cys143 is not 
involve in a disulfide bridge. Likewise, we cannot exclude whether purification 
of the recombinant proteins led to aging and oxidation of the cysteins and or 
building of the disulfide bridges. However, the fact that ceramidase, even more 
abundant than sphingomyelinase, is less active than sphingomyelinase might 
be due to only partially active protein, in which the majority of the Cys143 is 
involved in disulfide bridges. Nevertheless, in our preparation of the protein we 
could not detect any disulfide bridges. 
 
3.4 Cross-linking experiment between acid ceramidase and Saposin D 
The lysosomal degradation of ceramide is catalyzed by acid ceramidase and 
requires saposin activator protein D (Sap-D) as cofactors in vivo. To further 
investigate whether a binding domain exists between acid ceramidase and 
Sap-D in vivo, BHK cells overexpressing saposin precursor and subsequently 
Sap-D were treated by L-photo-leucine. A cross-linking protein complex 
between 83 and 62 kDa was detected by acid ceramidase antibody as well as 
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by Sap-D antibody. Likewise, the cross-linking test between purified acid 
ceramidase and purified Sap-D in vitro, the same band could be recovered. 
Depending on the standard protein marker, this cross-linking protein complex 
consisted of acid ceramidase and Sap-D in the ratio 1:1. Interestingly, 
Unglycosylated Sap-D from recombinant expression in Pichia pastoris shows a 
dimerization of Sap-D. For ceramidase one can detect a band corresponding 
to a dimer and a tetrameric form. According to the model of lipid activation by 
Sap-D (Rossmann et al. 2008), the dimer Sap-D extracts lipid molecule from 
the membrane. Perhaps more importantly, ceramidase could subsequently 
interact with the dimer Sap-D and lipid molecule due to our cross-linking result. 
The next step of the process is the hydrolysis of lipid molecule from the 
complex. With the help of Sap-D acting as the “solubilizer” (Ciaffoni et al. 2001), 
water-soluble ceramidase could more effectively degrade ceramides from the 
lipid bilayer. 
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4 Summary 
Ceramides are important building blocks of eukaryotic membranes and 
primarily serve as membrane anchors of GSLs and sphingomyelins. The 
lysosomal degradation of ceramide is catalyzed by acid ceramidase and 
requires the interaction with Sap-D in vivo. Acid ceramidase is synthesized as 
a monomeric precursor followed by proteolytic processing into mature enzyme 
which is a heterodimer consisting of α- and β- subunits. The main goal of this 
study was to establish the recombinant expression in insect cells and 
purification of only the human acid ceramidase precursor for further 
crystallization studies. In order to generate the recombinant baculovirus 
expressing only the human acid ceramidase precursor, a fusion protein was 
constructed with SEAP. However, this strategy failed and proteolytic 
processing of acid ceramidase still occurred. Subsequently, the amino acids 
near the cleavage site were substituted by point mutation to avoid proteolytic 
processing. It only worked with the mutant of the nucleophilic Cys143, which 
did not show any proteolytic cleavage, whereas all other variants were still 
cleaved. Therefore, proteolytic processing of acid ceramidase seems to occur 
autocatalytically by self-cleavage into α- and β- subunits, similar to other 
members of the N-terminal nucleophile (Ntn) hydrolase superfamily. We 
established the overexpression and purification of the variant Cys143Ala 
fusion protein to produce a large amount of acid ceramidase precursor for 
further crystallization experiments. 
Treatment of wild-type fusion protein “SEAP-haCerase” with the cysteine 
protease inhibitor, p-chloromercuribenzoic acid (pCMB), inhibited both 
self-cleavage and enzymatic activity. More importantly, Cys143 residue was 
also confirmed to be in a free state. Therefore, we suggest that acid 
ceramidase also belong to the superfamily of Ntn-hydrolases. 
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5 Material and Methods 
5.1 Technical equipment and materials 
5.1.1 Technical equipment 
Technical equipment: Specification/Manufacturer City 
Analytical HPLC LDP10AT Shimadzu Duisburg 
Autoclave Systec Wettenberg 
Autosampler AS 200 Biorad München 
Blot apparatus Mini-Transblot Biorad München 
Centrifuges Sorvall RC 5B DuPont Bad Homburg 
Centrifuge rotors JA 10, Ti 80 Beckmann München 
Fluorescence detector RF 10AX Shimadzu Duisburg 
FPLC-System Pharmacia Biosystem Freiburg 
Gel apparatus Mini-Protean ll Biorad München 
Incubator 1083/Gesellschaft für Burgwedel 
 Labortechnik  
Isothermal titration calorimeter 
MALDI-MS TOF Spec E 
VP-ITC/ MicroCal 
Micromass 
Amherst, USA 
Mancheter, UK 
Perstaltic pump P1 Pharmacia Biosystem Freiburg 
pH-meter pH 537 WTW Weilsheim 
Power supply : model 250/2.5 Biorad München 
Preparative HPLC Biocad Sprint PE Biosystem Weiterstadt 
Table top centrifuges Modell 5412 Eppendorf Hamburg 
Thermomixer Comfort Eppendorf Hamburg 
Thermocycler: PTC-200 MJ-Research/Biozym Oldendorf 
Ultrasonic irradiation system Branson Danbury, USA 
Sonifier 250   
Ultraturrax TP 1810 Janke & Kunkel Staufen 
Votex MS Minishaker/Ika-Werk Staufen 
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Water filtration system Super Q Millipore Molsheim, 
  France 
5.1.2 Columns 
Columns: Specification/Manufucturer City 
Hiload XK26 
LiChroCART 125-4 Nucleosil 5 
Pharmacia Bioteck 
Merck 
Freiburg 
Darmstadt 
C18   
Q-Sepharose Hiload 26/20 Pharmacia Bioteck Freiburg 
Superdex 75 Pharmacia Bioteck Freiburg
5.1.3 Chemicals 
Chemical: Specification/Manufacturer City 
Acetic acid Merck Darmstadt 
Acrylamide solution 29:1, 30% Biorad München 
Alkaline phosphatase, conjugated 
to anti-goat lgG 
Sigma 
 
Deisenhofen
Ammoniumperoxodisulfate Bioland München 
BCA solution Sigma Deosemjpfem 
Buffer salts Merck Darmstadt 
Ceramides Matreya Lipids Köln 
Chloroform, p.a. Fluka Neu-Ulm 
p-chloromercuribenzoic acid Fluka Neu-Ulm 
Colloidal Coomassie Blue, ICN Eschwege 
Image Enhancer   
Coomassie Blue G250 Serva Herdelberg 
DEAE sepharose Sigma Deisenhofen 
Fluoroaldehyde Pierce Rockford, USA 
β-Mercaptoethanol Sigma Deisenhofen 
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Methanol HPLC-grade Riedel-de Haen Seelze 
Ni-NTA superflow Qiagen Hilden 
PVDF membranes Porablot, Macherey-Nagel Dassel 
Restriction-enzyme: Bam HI, 
Kpn I, Sal I, Bgl II 
NEB 
 
Schwalbach 
 
SDS Sigma Deisenhofen 
Silver nitrate Merck Darmstadt 
Sodium cholate 
T4-DNA-Ligase 
Deisenhofen 
NEB 
Sigma 
Schwalbach 
Taq-DNA-Polymerase NEB Schwalbach 
TCEP Pierce ckford, USA 
Tev Proteas Invitrogen San Diego, USA 
TEMED Roth Karlsruhe 
Tricin ultra pure ICN Eschwege 
Tris ultra pure ICN Eschwege 
Triton X-100 Sigma Deisenhofen 
Trypsin, modified, sequencing Promega Mannheim 
grade   
Tween 20 Sigma Deisenhofen 
5.1.4 Kits 
Chemical: 
Expand LongTemplate PCR 
Specification/Manufacturer 
Roche 
City 
Mannheim 
System   
QIAprep Spin Miniprep-Kit 
QIAquick Gel Extraktion-Kit 
Qiagen 
Qiagen 
Hilden 
Hilden 
QuikChange XL Site-Directed 
  mutagenesis kit 
Stratagene 
 
La Jolla/USA 
 
Western Lightning Western-Blot 
  Detection Kit 
Pierce 
 
Ckford, USA
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5.2 Methods 
5.2.1 Cells and cell culture 
Sf9 cells are derived from IPLB-Sf21-AE, an established cell line originally 
isolated from Spodoptera frugiperda ovaries. This cell line was maintained as a 
suspension culture in a glass flask by continuous rotation (135 rpm) at 26°C 
and maintained at a densities of 0.6 –3.0 x 106 cells / ml in complete IPL-41 
medium (JRH Biosciences, Lenexa, KS, USA), which supplemented with 
Pluronic F68 (10%) 
 
5.2.2 Construction of the expression plasmids pSEAP-haCerse 
To generate the recombinant baculovirus expressing the human acid 
ceramidase precursor, a fusion construct of secretory alkaline phosphatase 
(SEAP)-Tev cleavage site-acid ceramidase (haCerase) -Tev cleavage site- 
6His-tag was designed. The full-length cDNAs encoding acid ceramidase or 
SEAP were used as the templates to generate the new expression plasmids. 
For this purpose, the different genetic building blocks were amplified in several 
PCRs using “Expand LongTemplate PCR System” (Roche). For the 
amplification of SEAP-Tev cleavage site open reading frame from 
pSEAP2-Basic (clontech), forward primer (Sigma-Genosys) 5_ 
GATCAGATCTTCGCGAATTCGCCCACCATGCTGCTGCTGCTGCTGCTG-3
_ (with the added Bgl II site underlined) and reverse primer 
5_-CATCGTCGACGCCCTGAAAATACAGGTTTTCTGTCTGCTCGAAGCGG
CCGGC-3_ (with the added Sal I site underlined and Tev protease cleavage 
site in bold). In order to construct haCerase  with an additional 
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carboxyl-terminal sequence 6x histidine affinity tag and Tev protease cleavage 
site, we prepared a cDNA fragment by PCR with forward primer 
5_-GATCGTCGACCAGCACGCGCCGCCGTGGACAGAGGACTGCAGAAAA
TCAACC-3_ (with added Sal I site underlined) and reverse primer 
5_-CATCGGTACCGTGATGGTGATGGTGATGGGTCGTTGGGATATCGTAA
TCGCCCTGAAAATACAGGTTTTCCCAACCTATACAAGGGTCAGG-3_ (with 
the added Kpn I site underlined, 6x histidine in italic and Tev protease 
cleavage site in bold) were used to amplify the haCerase open reading from 
pCR-XL Topo vector (Leber, 1999) .  
 
Prepare the sample PCR reaction(s) as indicated below: 
5 μl of 10× reaction buffer 
1.5 μl (10 ng) of dsDNA template 
1 μl (20 pmol) of oligonucleotide downstream primer 
1 μl (20 pmol) of oligonucleotide upstream primer 
2.5 μl of dNTP (10 mM) mix 
ddH2O to a final volume of 50 μl 
Then add 0.75 μl of DNA polymerase (5 U/μl) 
 
Following PCR program: 
1 x cycle: 94 °C, 3 min. (Initial denaturation) 
15 x cycle: a) 94 °C, 15 sec. (Denaturation) 
b) 55 °C, 1 min. (Annealing)  
c) 68 °C, 2 min. (Elongation) 
1 x cycle: 68 °C, 5 min. (Final elongation) 
 
The PCR products: “SEAP-Tev” and “haCerase-6x His-Tev” fragments were 
digested by Bgl II, Sal I and Kpn I restriction enzymes then ligated into 
between the BamH I site and Kpn I site of the pFastBac transfer vector 
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(Invitrogen). The resulting plasmids were termed pSEAP-haCerase with a size 
of ~ 7584 bp. The recombinant plasmid was propagated in Escherichia coli 
DH5α. 
 
 
5.2.3 Construction of the expression plasmids pSEAP-haCersemut 
The QuikChange XL Site-Directed mutagenesis kit (Stratagene) was used to 
generate the pSEAP-haCerasemut vector expressing individually seven 
different point mutants (Thr141Val, Ile142Val, Cys143Ala, Cys143Met, 
Thr144Ala, Ser145Ala and Ser145Thr) of haCerase were conducted in 
accordance to manufacturer's recommendations. Only the PCR program was 
changed. (Cys143 of haCerase is the N-terminal amino acid of the β-subunit 
and is assumed to be the nucleophile of the catalytic center.) Seven pairs of 
complementary oligonucleotides (Sigma-Genosys) were used (The mutated 
codon are indicated in bold). 
T141V: upstream primer: 
5_-CAATATTTTTTATGAATTATTTGTCATTTGTACTTCAATAGTAGCAGAAG-3_. 
downstream primer: 
5_-CTTCTGCTACTATTGAAGTACAAATGACAAATAATTCATAAAAAATATTG-3_. 
I142V: upstream primer:  
5_- GAATTATTTACCGTTTGTACTTCAATAGTAGCAGAAGACAAAAAAGGTC-3_. 
downstream primer:  
5_- GACCTTTTTTGTCTTCTGCTACTATTGAAGTACAAACGGTAAATAATTC-3_. 
C143A: upstream primer:  
5_- GAATTATTTACCATTGCTACTTCAATAGTAGCAGAAGACAAAAAAGGTC-3_. 
downstream primer: 
5_-GACCTTTTTTGTCTTCTGCTACTATTGAAGTAGCAATGGTAAATAATTC-3_. 
C143M: upstream primer:  
5_- GAATTATTTACCATTATGACTTCAATAGTAGCAGAAGACAAAAAAGGTC-3_. 
downstream primer: 
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5_- GACCTTTTTTGTCTTCTGCTACTATTGAAGTCATAATGGTAAATAATTC-3_. 
T144A: upstream primer: 
5_- GAATTATTTACCATTTGTGCTTCAATAGTAGCAGAAGACAAAAAAGGTC-3_. 
downstream primer:  
5_- GACCTTTTTTGTCTTCTGCTACTATTGAAGCACAAATGGTAAATAATTC-3_. 
S145A: upstream primer:  
5_- GAATTATTTACCATTTGTACTGCTATAGTAGCAGAAGACAAAAAAGGTC-3_. 
downstream primer: 
5_- GACCTTTTTTGTCTTCTGCTACTATAGCAGTACAAATGGTAAATAATTC-3_. 
S145T: upstream primer: 
5_- GAATTATTTACCATTTGTACTACTATAGTAGCAGAAGACAAAAAAGGTC-3_. 
downstream primer: 
5_- GACCTTTTTTGTCTTCTGCTACTATAGTAGTACAAATGGTAAATAATTC-3_. 
 
Prepare the sample PCR reaction(s) as indicated below: 
5 μl of 10× reaction buffer 
1 μl (30 ng) of dsDNA template: pSEAP-haCerase 
1 μl (125 ng) of oligonucleotide downstream primer 
1 μl (125 ng) of oligonucleotide upstream primer 
2 μl of dNTP mix 
3 μl of QuickSolution 
ddH2O to a final volume of 50 μl 
Then add 1 μl PfuTurbo DNA polymerase (2.5 U/ μl) 
 
Following PCR program: 
1 x cycle: 95 °C, 1 min. (Initial denaturation) 
16 x cycle: a) 95 °C, 50 sec. (Denaturation) 
b) 64 °C, 50 sec. (Annealing) 
c) 68 °C, 10 min. (Elongation) 
1 x cycle: 68 °C, 7 min. (Final elongation) 
 
After transformation into XL10-Gold ultracompetent cells, the mutant sites 
were sequenced again (SeqLab GmbH). 
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5.2.4 Recombinant fusion protein expression 
For expression in Sf9 insect cells according to Bac-to-Bac baculovirus 
expression system protocol, the recombinant plasmids (pSEAP-haCerase or 
pSEAP-haCerasemut) constructs were transformed into E. coli 
DH10Bac-competent cells containing the circular baculovirus genone to 
generate recombinant bacmids per manufacturer’s protocol (Invitrogen). The 
Bacmid DNAs were prepared and transfected into Sf9 cells using Transfection 
Buffer A and B Set (BD Biosciences) to produce recombinant baculoviruses 
that were amplified with a titler of 3.2 x 108 PFU/ml and used to express wild 
type: “SEAP-haCease” fusion protein or mutant: “SEAP-haCerasemu”t fusion 
protein in insect cells. 
 
5.2.5 Purification of recombinant acid ceramidase 
For preparative expression and purification of mutant fusion protein 
(Cys143Ala), stably transformed Sf9 cells were cultured as 800 mL 
suspension cultures in 2 L flask to a final density of 2.2 x 106 cells/mL. Since 
the expression level reached an approximate plateau after 96 hours, at this 
time point, the medium was harvested by centrifugation (6500 rpm, 30 min.) 
and kept at 4°C. The supernatant was then concentrated 10-fold by 
VivaFlow 200 (Vivascience) with filter-membrane 100,000 MW (PES), and 
then the concentrated medium exchanged to DEAE-Sepharose equilibration 
buffer (50 mM Tris/HCl; 100 mM NaCl, pH 7.4) by dialysis (Serva) overnight. 
After centrifugation (10000 rpm, 30 min.), the buffer-exchanged supernatant 
(200 ml) was then loaded with a rate of 2 ml/min onto DEAE-Sepharose 
(column dimensions: 2.6 x 15 cm, Sigma), which was pre-equilibrated with 
Material and Methods 
63 
 
wash buffer (50 mM Tris-HCl, 100 mM NaCl, pH 7.4). The suspension of 
flow-through was collected. After overnight dialysis with Ni-NTA wash buffer 
(50 mM NaH2PO4, 300 mM NaCl, 20 mM imidazole, pH 7.8), the suspension 
was clarified by centrifugation (10000 rpm, 30 min) and sterile filtration (0.2 
μm). The filtrate was loaded with a rate of 1 ml/min onto a Ni-NTA superflow 
column (column dimensions: 1.6 x 4.5 cm, Qiagen). After the column was 
washed with 4 column volumes of Ni-NTA wash buffer, absorbed proteins 
were direct eluted in 20 ml elution buffer (50 mM NaH2PO4, 300 mM NaCl, 125 
mM imidazole (pH 7.8)). The eluted sample was then concentrated 5-fold by 
Vivaspin 20 concentrater (Vivascience) with filter-membrane 100,000 MW 
(PES), 2000 rpm, and then the concentrated sample (final volume:~2 ml) was 
loaded with a rate of 1 ml/min onto gel filtration column: Superdex 75 Hiload 
16/60 with running buffer (50 mM Tris/HCl, 200 mM NaCl, pH 7.6) in FPLC 
system (GE Healthcare). Pooled fusion protein “SEAP-haCerasemut” fractions 
(Number:14~19.) were concentrated (final volume: ~2 ml) and buffer exchange 
with Tev-buffer (50 mM Tris/HCl, pH 7.6, 0.5 mM EDTA, 1 mM DTT) using 
Vivaspin 20 (Vivascience). AcTEV protease (Invitrogen) cleavage reaction was 
performed for three hours at room temperature following manufacturer’s 
protocol. The digested sample was loaded again onto the same gel fitration 
column: Superdex 75 Hiload 16/60 in FPLC system. The new appeared peak´s 
fractions were collected, containing the purified enzyme ”haCerase” without 
SEAP and 6x histidine amino acids. 
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5.2.6 Determination of acid ceramidase activity with a micellar assay 
system 
Acid ceramidase activity in the detergent-containing micellar assay system 
was measured, with minor Modification, according to Bernardo et al. (1995). 
5.2.6.1  Composition of incubation mixture and assay conditions
The incubation mixture contained in a final volume of 100 μl: 10-50 μl undiluted 
enzyme solution, 17 nmol N-lauroyl sphingosine, solubilized in 0.5 % (w/v) 
Triton X-100, 0.2 % (w/v) Tween 20, 0.2 % (w/v) NP-40 and 0.8 % (w/v) 
sodium cholate, 250 mM sodium acetate buffer (pH 4.0) and 5 mM EDTA. The 
enzyme assays were incubated for 30 min at 37 °C. 
5.2.6.2  Sample preparation and HPLC analysis of sphingoid bases  
Enzyme reaction was terminated by adding 800 μl HPLC-grade (2:1, v/v) 
chloroform/methanol and 200 μl of 100 mM ammonium hydrogen carbonate 
solution. D-erythro-1,3-dihydroxy-2-aminotetradecane (C14-sphinganine) and 
D-erythro-1,3-dihydroxy-2-aminohexadecane (C16--sphinganine), solubilized in 
HPLC-grade methanol, were added to the incubation mixture as internal 
standards (500 pmol each). Samples were mixed for 10 min and then 
centrifuged for 5 min at 10,000 x g. The lower chloroform phase containing the 
liberated sphingosine and internal standards was carefully removed and 
collected in a fresh vial. For quantitative recovery of sphingosine and the 
internal standards the extraction was repeated by adding 600 μl (2:1 v/v) 
chloroform/methanol to each incubation vial. The following extraction steps 
were performed as described above. The combined organic phases were 
evaporated to dryness under a stream of nitrogen. The dried enzyme assays 
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were solubilized in 50 μl HPLC-grade ethanol and mixed for 10 min at 50°C. 
Samples had cooled down to room temperature. 50 μl Fluoroaldehyde (Pierce) 
were added to each incubation vial. Alternatively, ο-phtaldialdehyde reagent 
solution was prepared as follows: 100 μl of an ethanol solution containing 5 mg 
of ο-phtalaldehyde and 5 μl β-mercaptoethanol were added to 9.9 ml of a 3 % 
(w/v) boric acid solution, adjusted to pH 10.5 with KOH. Samples were mixed 
for 5 min at room temperature and then diluted with 0.9 ml HPLC buffer 
(acetonitril/2 mM potassium phosphate, pH 7.0, 9/1 v/v) to a final volume of 1 
ml. An aliquot of each sample (100-200 μl) was injected onto a LiChroCART 
125-4 Nucleosil 5 C18-column (125 x 4 mm, Merck), equilibrated in HPLC 
buffer. The derivatized sphinganine and sphingosine bases were eluted 
isocratically (flow rate: 1 ml/min, Shimadzu LC-10 AT solvent delivery system) 
and detected by a fluorescence detector (Shimadzu RF-10 AX, excitation 
wavelength: 355 nm, emission wavelength: 435 nm). Quantification of 
liberated sphingosine was performed with a Window based standard liquid 
Chromatography software (Class CR-10, Shimadzu). 
 
5.2.7 Protein quantification 
Protein concentrations were determined with the BCA method (Smith et al. 
1985). Concentration measurements were carried out in duplicates in a 96-well 
microtiter plate. Protein containing samples (20 μl) were mixed with 200 μl of a 
BCA-copper sulfate solution. The BCA-copper sulfate solution was prepared 
by mixing 49 parts of BCA solution (pH 11.5) with 1 part 4 % (w/v) copper 
sulfate solution. Samples were incubated for 30 min at 60°C. Under the 
alkaline assay conditions proteins reduce Cu (II) to Cu (I) which forms a 
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complex with BCA. The Cu (l) -BCA complex was measured at 595 nm in a 
microplate photometer. Protein concentrations were determined by 
comparison to a calibration curve generated with BSA solution of known 
concentration (0-5 μg/20 μl). 
 
5.2.8 SDS-PAGE analysis 
SDS-PAGE analysis of proteins was performed according to the protocol of 
Schägger and von Jagow (Schagger et al. 1987). Proteins were heated in 
sample buffer (3.0 M Tris/HCl, pH 8.45; 0.3 % SDS; ± 5 % (v/v) 
β-mercaptoethanol) for 5 min at 95°C. Denatured proteins were 
electrophoresed in a mini-gel apparatus (100 x 70 x 0.75 mm, Biorad) with 4 % 
concentration gel (running distance 1 cm) and 8 % separation gel (running 
distance 6 cm). Electrophoresis was first carried out at 20 mA constant current 
until the dye front reached the separation gel. The current was then raised to 
constant 30 mA. Electrophoresis was terminated when the dye front reached 
the bottom of the gel.  
 
5.2.9 Visualization of proteins by colloidal Coomassie Blue R 250 
After electrophoresis, gels were incubated for 60 min in a fixation solution (40 
% MeOH, 10 % AcOH (v/v)). Gels were stained for 2 hours with a colloidal 
Coomassie Blue solution (ICN). Image enhancement was achieved by 
incubating the gel for 10 min with a developer solution (25 % EtOH, 8 % AcOH 
(v/v)). Gels were destained with an acetic acid solution (10 % (v/v)). 
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5.2.10 Silver staining of proteins 
Silver staining of proteins in SDS-PAGE gels was carried out according to . 
After electrophoresis, gels were incubated for 60 min in a fixation solution (50 
% (v/v) MeOH, 12 % (v/v) AcOH, 0.5 ml/L formaldehyde solution 37 % (v/v)). 
Gels were then washed 3 x 20 min with 50 % (v/v) EtOH. After the washing 
step, gels were treated for 1 min with incubation solution (0.2 g/L Na2S2O3 x 5 
H2O). Gels were then impregnated for 20 min with a silver ion solution (2 g/L 
AgNO3, 0.75ml/L formaldehyde solution (37 %)). Excess silver stain was 
removed by washing the gels briefly with water. Proteins were visualized by 
incubating the gel with developing solution (60 g/L Na2CO3, 4 mg/L Na2S2O3 x 
5 H2O, 0.5 ml/L formaldehyde solution (37 %)). Development was terminated 
with a stop solution (50 % (v/v) MeOH, 12 % (v/v) AcOH) as soon as the first 
protein bands became visible. In order to remove excess acetic acid a final 
fixation step (30 % (v/v) MeOH, 3 % glycerol) was carried out. Gels were air 
dried between two cellulose sheets. 
 
5.2.11 Western blot analysis 
Immunochemical detection of SDS-PAGE separated proteins was carried out 
after proteins were electrophoretically transfered onto PVDF membranes using 
a tank blotting procedure. After electrophoresis, gels were equilibrated for 15 
min in transfer buffer (10 mM 3-(cyclohexylamino)- 1-propanesulfonic acid 
(CAPS) buffer, pH 11, 10% (v/v) methanol). After equilibration, gels were laid 
on top of a MeOH-wetted PVDF membrane. Protein transfer was performed at 
a current of 400 mA for 36 min in a Mini-Trans-Blot apparatus (Biorad). After 
transfer of proteins, PVDF membranes were incubated for 60 min at room 
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temperature with blocking solution (5% low-fat milk in TBST buffer (10 mM 
Tris-HCl pH 8, 150 mM NaCl and 0.05% Tween 20) and than incubated with 
polyclonal rabbit anti-human acid ceramidase antiserum (dilution 1:1000) 
raised against expressed human acid ceramidase. The membrane was 
washed three times with TBST buffer. Detection of acid ceramidase was 
performed using antirabbit- IgG-HRP conjugate as secondary antibody (diluted 
1:10,000 in TBST). Proteins were visualized with the SuperSignal west pico 
chemiluminescent substrate Kit (Pierce). 
 
5.2.12 In-gel tryptic digestion and MALDI Mass spectrometry 
The purified recombinant fusion proteins (0.8 mg) were running onto the lane 
of 8% SDS PAGE under reducing condition. After Coomassie-staining, the 
bands of recombinant fusion protein “SEAP-haCerase” were excised as gel 
slices and then were incubated with modified trypsin (Promega) overnight at 
37°C. The tryptic peptides were extracted according to standard protocol 
(Shevchenko et al. 2006) prior to Mass spectrometry. 
MALDI-TOF-MS analysis was performed in positive mode on a TofSpec E 
mass spectrometer (Micromass) with a 337 nm nitrogen laser. The 
acceleration voltage was set to 20 kV. An extraction voltage of 19.5 kV and a 
focus voltage of 15.5 kV were used. A pulse voltage of 2200–2400 V was used 
for measurements in the reflectron mode and of 1200 V for measurements in 
the linear mode with the high mass detector. Measurements were performed at 
threshold laser energy. α-Cyano-4-hydroxycinnamic acid (Sigma) (10 mg/ml in 
50% acetonitrile (Merck), 50% water containing 0.1% trifluoroacetic acid 
(Sigma)) for peptides or sinapinic acid (Sigma) (10 mg/ml in 40% acetonitrile, 
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5.2.13.1 
60% water containing 0.1% trifluoroacetic acid) for proteins were used as 
matrices. The peptide solution was mixed with the matrix solution (each 1 μl) 
on the target and dried at room temperature. Calibration was performed using 
standard peptides. 
 
5.2.13 Cross-linking experiment between acid ceramidase and Sap D 
Cross-linking test in vivo 
Labeling with L-photo-Leucine: 
BHK (baby hamster kidney) cells were grown in high-glucose DMEM (Gibco; 
with L-glutamine and sodium pyruvate) with 10% fetal calf serum (FCS). 
Typically, 5 cm2 of cells are needed for a cross-linking experiment with 
detection by Western blot. At about 70% confluence, medium was replaced by 
DMEM-LM (DMEM lacking L-leucine and L-Methionine, supplemented with 5% 
dialyzed FCS and 30 mg/L L-Methionine). L-photo-Leucine was added to a 
final concentration of 4 mM, and cells were cultivated for 24 h, washed with 
phosphate-buffered saline (PBS) and UV-irradiated using a 365 nm lamp for 
15 min. The samples were placed at a distance of 4 cm from the light source. 
Cells were harvested, washed twice with PBS, and resuspended in lysis (RIPA) 
buffer (10 mM Tris pH 7.5, 150 mM NaCl, 10% glycerol, 1% NP-40, 5 mM 
EDTA) containing a cocktail of protease inhibitors (Roche Diagnostics). Cell 
lysates were centrifuged for 15 min at 14 000 rpm. Supernatants were 
collected following by SDS PAGE and Western blot as above. 
Chemical cross-linking: 
BHK cells were grown in DMEM, washed with PBS, incubated with 1% 
paraformaldehyde (PFA) in PBS for 30 min on ice, and finally quenched for 15 
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5.2.13.2 
min with10 mM Tris (pH 8.5). Cell lysis and processing for SDS PAGE and 
Western blot was done as above. 
Cross-linking test in vitro 
Due to the presence of amino group in Tris/HCl buffer, the Tris/HCl buffer of 
gel filtration in FPLC system was exchanged with PBS buffer (100 mM 
phosphate, 200 mM NaCl, pH 7.6). After Tev cleavage reaction, the sample 
was loaded into FPLC with PBS buffer and then the purified acid ceramidase 
was ready for cross-linking test. 
Add a 48-fold molar excess of DSG (between 0.25-5 mM) to the protein 
sample (acid ceramidase and Sap-D in molar ratio 1:1 or 1:2) at room 
temperature for 30 min, and finally quenched for 15 min with 500 mM Tris (pH 
8.5). The treated sample for SDS PAGE and Western blot was done as above. 
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7 Abbreviations 
AcOH 
BCA 
acetic acid 
Bicinchoninic Acid 
BEVS baculovirus expression vector system 
BHK baby hamster kidney 
BMP bis(monoacylglycero)phosphate 
BSA bovine serum albumin 
CER 
Cys 
Ceramide 
cysteine 
DEAE diethylaminoethyl 
DMSO 
DSG 
Dimethylsulfoxide 
Disuccinimidyl glutarate 
DTT dithiothreitol  
EC enzyme classification  
EDTA ethylendiamine  
ER endoplasmic retikulum  
EtOH ethanol  
g gravitational force  
GSL glycosphingolipid  
h 
haCerase 
hours 
human acid ceramidase 
HPLC 
IgG 
high pressure liquid chromatography 
Immunoglobulin G  
k kilo  
MALDI matrix assisted laser desorption ionization  
MeOH methanol  
min minutes 
mg milligram 
Abbreviations 
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mM 
MOI 
milli molar 
Multiplicity of infection 
μM micro molar  
MS mass spectrometry  
n nano  
NaAc sodium acetate  
NaCi sodium citrate  
NBT nitrotetrazolium blue  
nm nano meter  
NP-40 nonidet P 40  
OPA ortho-phthaldialdehyde 
PAGE polyacrylamide gel electrophoresis  
PBS phosphate buffered saline  
PC 
PCR 
PFA 
PFU 
phosphatidylcholine  
Polymerase chain reaction 
paraformaldehyde 
plaque-forming units 
PG phosphatidylglycerol  
Pl phosphatidylinositol  
pl isoelectric point  
PMSF phenylmethylsulfonylfluoride  
PVDF poly(vinylden)diflouride  
RT room temperature  
SAP sphingolipid activator protein  
SDS 
SEAP 
sodium dodecylsulfate  
secretory alkaline phosphatase 
Sf 
Tev protease 
spodoptera frugiperda 
Tobacco Etch Virus protease 
TFA trifluoroacetic acid  
Abbreviations 
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Tricine N-[tris(hydroxymethyl)methyl]glycin 
Tris 
v/v 
w/v 
tris(hydroxymethyl)aminomethane 
volume per volume 
weight per volume
Supplements 
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8 Supplements 
           .
Tryptic peptides with at least 3 amino acid residues 
 
[M+H]+ 
calculated 
(Da) 
[M+H]+ 
measured 
(Da) 
T1 (-)QHAPPWTEDCR  
T3 STYPPSGPTYR  
T4 GAVPWYTINLDLPPYK  
T6 WHELMLDK  
T7 APMLK  
T8 VIVNSLK  
T9 NMINTFVPSGK  
T10 VMQVVDEK  
T11 LPGLLGNFPGPFEEEMK  
T12 GIAAVTDIPLGEIISFNIFYELFTI(-) 
T13 (-)CTSIVAEDK  
T15 GHLIHGR  
T16 NMDFGVFLGWNINNDTWVITEQLKPLTVNLDFQR 
T17 NNK  
T18 TVFK  
T19 ASSFAGYVGMLTGFKPGLFSLTLNER   
T20 FSINGGYLGILEWILGK  
T22 DAMWIGFLTR  
T23 TVLENSTSYEEAK  
T24 NLLTK  
T25 ILAPAYFILGGNQSGEGCVITR 
T26 ESLDVYELDAK  
T30 QGR  
T31 WYVVQTNYDR  
T33 HPFFLDDR  
T35 TPAK  
T36 MCLNR  
T37 TSQENISFETMYDVLSTKPVLNK  
T38 LTVYTTLIDVTK  
T39 GQFETYLR  
T40 DCPDPCIGW  
1339.59 
1225.59 
1846.97 
1071.53 
559.33 
772.49 
1207.61 
947.49 
1874.94 
2756.48 
964.45 
789.45 
4038.02 
375.20 
494.30 
2763.42 
1880.03 
1209.61 
1470.70 
588.37 
2279.19 
1281.62 
360.20 
1343.64 
1046.51 
416.25 
636.30 
2644.32 
1366.78 
1013.51 
1005.38 
– 
1225.46 
1847.60 
1071.67 
– 
– 
1207.71 
– 
1875.59 
2756.82 
– 
789.54 
– 
– 
– 
2764.06 
1880.62 
1209.56 
– 
– 
- 
– 
– 
1342.56 
1046.55 
– 
– 
2644.62 
1366.54 
1013.46 
– 
 
Table of MALDi and ESI fragments of human acid ceramidase (Taken from Schulze et 
al, 2007) 
